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The 2-His-1-carboxylate facial triad is a common metal binding motif among
nonheme iron(II) enzymes. Made up of two histidine side chain residues, and one
carboxylate side chain of either a glutamate or aspartate residue occupying one face of
the iron(II) octahedral coordinating sphere, the 2-His-1-carboxylate motif provides
proximity of substrate(s) and molecular oxygen for important oxidation reactions in
biological chemistry. Computational, structural, and kinetic analyses have afforded
mechanistic details on how these enzymes control the oxidation reactions they catalyze;
from the oxidation state of the metal center to the supporting interactions from secondary
sphere amino acid residues. However, the extensive literature on the 2-His-1-carboxylate
facial triad enzymes currently contains deficiencies in the area of fundamental,
experimental thermodynamic analyses of metal and substrate binding in these systems.
The focus of this study is to determine the energetics of substrate and metal
binding to two representative enzymes of the 2-His-1-carboxylate facial triad-containing
family. More specifically, we examine iron(II) binding to the alpha-ketoglutarate-

dependent model system alpha-ketoglutarate/taurine dioxygenase, and substrate binding
to a well-known extradiol dioxygenase, homoprotocatechuate 2,3-dioxygenase. Using
isothermal titration calorimetry, we are able to determine equilibrium constants,
enthalpies, entropies and Gibbs free energies for the binding reactions, affording new
insight into what drives the reactions forward at the 2-His-1-carboxylate facial triad
active site center.
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CHAPTER I
THE NON-HEME IRON(II) ENZYMES

1.1

Introduction
Molecular oxygen plays an important role in many biological processes

significant to the environment and human health.1-3 The most recognizable of these
processes is its role in aerobic respiration where oxidative phosphorylation yields ATP,
the energy source of cellular processes. A delicate balance by nature is required for
reactions involving dioxygen to proceed; without regulation the accumulation of reactive
oxygen species can result in cell damage.4
Reactions involving molecular oxygen are by and large not favorable due to spin
limitations: most molecular compounds exist in a singlet state, whereas O2 primarily
exists in a triplet state.5 However, Nature has adapted to utilize paramagnetic iron(II)
metal ions at the center of many enzymes to allow for the coordination of O2 and
cosubstrates in proximity to each other on the metal coordination sphere. In many cases,
the iron(II) metal ion at the active site center is involved in 2- or 4- electron oxidation
reactions using molecular oxygen as a substrate that can result in high-valent intermediate
states of the metal which is important in the biological reactions they catalyze.6 It is the
favorable redox potential of the iron(II) center, in combination with the contributions of
the amino acid side chains and globular protein structure that allow these enzymes to
provide a breadth of catalytic functions. 7

1

One example of a nonheme iron(II) oxidase is Isopenicillin N Synthase (IPNS).
IPNS is one enzyme in a series of bacterial and fungal enzymes that synthesize penicillin
N and its derivatives.6,8 IPNS is responsible for the ring closure reaction of δ-(L-αaminoadipoyl)-L-cysteinyl-D-valine to isopenicillin N by hydrogen atom abstraction of
the substrate, and formation of two water molecules in the process (Scheme 1.1).9
Through computational methods, it has been determined that this chemistry occurs
through a high-valent iron(IV)-oxo species.10 Iron(IV)-oxo intermediates are common
among oxygenase enzymes and are thought to be the key intermediate species for
catalysis.11

Scheme 1.1 IPNS-Catalyzed Ring Closure Reaction

Cysteine dioxygenase (CDO) is a prime example of an iron(II) enzyme, in which
utilization of dioxygen results in the incorporation of both oxygen atoms into the product
compounds.12 There is an abundance of iron(II) enzymes categorized into the oxygenase
family, and many use similar chemistry at the active site core to catalyze their respective
reactions.5,13,14 In the case of CDO, the conversion of cysteine to cysteine sulfinic acid is
2

a physiologically important reaction to reduce toxic levels of cysteine in mammals
(Scheme 1.2).

Scheme 1.2 Reaction Catalyzed by Cysteine Dioxygenase

In addition to the two examples listed above, there are a host of iron(II) enzymes
that depend on the oxidation of α-ketoglutarate (αKG) to supply electrons for a coupled
reaction with additional substrates, and as many as ten sub-families can be discerned in
the αKG family by their structural aspects.15-17 α-Ketoglutarate is found readily in
biology where it is a part of the citric acid cycle, the center of metabolism in living
systems. The citric acid cycle can supply biological compounds to several physiologically
relevant reactions, thus intermediates within the citric acid cycle are highly regulated. For
example, citrate is the first intermediate within the cycle and is often used for the
synthesis of fatty acids and cholesterol.18 α-Ketoglutarate can be siphoned from the citric
acid cycle to serve as a cofactor in many oxidation reactions, and reenters the cycle only
a few metabolic steps later as succinate, evading the depletion of many intermediates
within the cycle. In this way, Nature has found a clever and efficient way of utilizing the
surroundings to catalyze reactions. Examples of such αKG-dependency are the alkylated
3

DNA repair (AlkB) enzymes and their human homologue family (ABH). These enzymes
contain a mononuclear iron(II) center where the repair of methylated DNA bases (N1methyladenine and N3-methylcytosine) occurs.19-23 This chemistry relies on the use of
αKG and dioxygen with iron(II) to regenerate the nucleotides concurrently with
formation of succinate, carbon dioxide, and formaldehyde (Figure 1.1).24 This reaction is
highly important in DNA base mismatch repair and gene silencing, where misregulation
can be linked to some cancers.25-27 Because of this, research in the area of DNA and RNA
demethylation and on the iron(II) enzymes that play a crucial role in these reactions has
exploded over the past five years. 20,28-33

4

Figure 1.1

DNA Demethylation by AlkB

The reaction catalyzed by AlkB in the presence of molecular oxygen and αKG. The
crystal structure illustrates the proposed base-flipping mechanism of AlkB to repair
methylated DNA, with αKG bound to the metal(II) center (white). In this case,
manganese(II) was used at the active site center to bind the substrates, which does not
support turnover. PDB: 1BI3. Image generated in PyMOL
With such a broad range of chemical reactions taking place at iron(II) centers, it’s
fascinating to note that numerous nonheme iron(II) enzymes also share the same amino
acid ligation motif to the metal center.5,34-38 This characteristic iron(II) metal binding
motif involves ligation by the ε nitrogen of two histidine side chain residues and the
carboxylate group from either an aspartate or glutamate side chain residue to form what is
known as the 2-His-1-carboxylate facial triad (2H1C), illustrated in Figure 1.2A. These
three amino acid side chains occupy one face of the iron(II) octahedral coordination
sphere, leaving three sites solvated on the adjacent face to give a six coordinate iron(II)
5

center. The solvent molecules are easily displaced when a substrate molecule binds.
There are several examples of substrates binding in a bidentate fashion to iron(II),
displacing all three solvent molecules which results in a five coordinate iron(II) system
that is poised for dioxygen binding.39-41 Most often, the six-coordinate system is
unreactive towards dioxygen, lending nature a way to control the formation of reactive
oxygen species within living systems through coordination chemistry.

Figure 1.2

The 2-His-1-Carboxylate Facial Triad

A. The structure of the 2H1C bound to a nonheme iron(II) metal center. The histidine
residues are coordinated to the iron(II) center through the ε nitrogen of the imidazole
rings. The ligation motif allows for solvation of one face of the iron(II) octahedron,
which is easily displaced when substrates bind.
B. A representative illustration of the 2H1C within an enzyme. The non-coordinated
oxygen of Asp101 is positioned to H-bond with a water molecule, and is thought to be
important in maintaining the H-bond network within the active site. PDB: 1OS7 Image
generated in PyMOL.

6

Extensive research has been performed to discern the importance of this metal
binding motif to the overall catalytic function of these nonheme iron(II) enzymes.36,42,43
There are several iron(II) oxygenase enzymes belonging to the cupin superfamily that
have been found to contain an atypical metal ligation motif that involves three histidines,
or occasionally three histidines and one carboxylate residue.14 In some cases, the
carboxylate residue is displaced upon substrate binding, which could indicate a role for
the carboxylate in the stability of the iron(II) ion in the active site. CDO is a member of
the cupin superfamily that contains a three histidine ligation motif, and various mutations
to create a 2H1C motif resulted in either a weakening of the iron-substrate bond, or
changes to the activation energies that make it too high to overcome.44 Moreover, IPNS
has been identified as containing an additional residue in the 2H1C, but point mutations
within the enzyme have indicated that the additional ligand is not necessary in the
ligation of the iron(II) ion, nor is it essential in the catalytic function of IPNS.45
Mutations to the 2H1C motif in αKG dependent taurine dioxygenase (TauD)
indicate that only one of the coordinating histidine residues (His99) is absolutely
necessary for catalytic function.46 The remaining histidine (His255) can be substituted by
a glutamate or glutamine residue, which is coordinated trans to the O2 binding site, and
still maintain high activity. However in this αKG dependent enzyme, the H-bonding
nature of the non-coordinated oxygen of the carboxylate ligand is essential for
interactions with a local water molecule (Figure 1.2B).47 Therefore, substitution by a
glutamate residue in this position allows for preservation of the H-bond network and
affords the enzyme to retain some of its catalytic activity.

7

Figure 1.3

Substrate Binding Modes

A. Bidentate binding of 3,4-dihydroxyphenylacetate to the iron(II) center of HPCD.
Substrate binds trans to both His residues, leaving an open site for dioxygen to bind trans
to the glutamate. PDB: 4GHG
B. αKG also binds bidentate to the iron(II) center of TauD. In this case, the substrate
binds trans to His99 and the carboxylate of Asp101. This has significance with regards to
the carbon dioxide leaving group, as it is poised trans to the carboxylate. PDB: 1OS7
The placement of the three endogenous ligands in a facial coordination geometry
is important to the enzyme’s function, and is determined by the amino acid sequence and
structure of the enzyme. For example, in the extradiol dioxygenase family of enzymes
the exogenous ligands bind to the iron(II) trans to the two histidine side chains (Figure
1.3A),48 leaving the open coordination site opposite the carboxylate ligand. However, in
TauD the αKG binds trans to a histidine (His99) and the carboxylate (Asp101) residue
(Figure 1.3B), leaving the open site opposite His255 to be occupied by dioxygen as
previously discussed. It is interesting to note that the catalytic cycle of the extradiol
dioxygenases is thought to contain an iron(II)-alkylperoxo species,49 whereas it has been
observed in αKG dependent enzymes that an iron(IV)-superoxo is the catalytic species.50
Perhaps structural positioning of both the exogenous and endogenous ligands leads to
8

stabilizing these specific intermediates. Evidence of this exists in the stereochemistry of
the active sites of αKG oxygenases, where facial versus meridional orientations can
dictate O2 activation pathways.17 More specifically, when αKG binds trans to the
endogenous carboxylate, there is a favorable flow of electrons between the pi orbitals of
iron-O2 and αKG due to their physical positions in space (Figure 1.4).38 In addition to
this, the back-bonding between the αKG and iron is enhanced when the keto group is
located trans to the anionic ligand. In the case of meridional orientation, the positioning
of O2 and the keto group trans to the carboxylate ligand does not occur, and therefore O2
activation cannot be supported through favorable electronic contacts.

Figure 1.4

Facial versus Meridional Isomers

Alpha-ketoglutarate-dependent enzymes require the 2H1C facial stereochemistry so that
the keto group is bound trans to the endogenous carboxylate residue, stabilizing the bond
and supporting O2 chemistry.17
9

The importance of the 2H1C ligands for non-heme iron(II) enzymes is evident,
but the choice of metal ion is also important to the optimal functionality of these
enzymes. Metal substitution experiments have been performed on a number of enzymes
to provide insight into the specific role of the iron(II) ion. Bleijlevens et al. reported the
successful replacement of copper(II) and cobalt(II) in AlkB,51 and Hausinger and
coworkers have replaced the iron(II) center of TauD with numerous transition metals
including zinc(II), nickel(II), copper(II) and cobalt(II), where the majority of these metal
ions had lower apparent affinities for the 2H1C active site.52 The extradiol dioxygenases
HPCD and MndD, homologous enzymes from different species that both cleave the
aromatic ring of 3,4-dihydroxyphenylacetate, contain iron(II) and manganese(II)
respectively at their active site centers, however the two metals can be easily
interchanged in each enzyme and still retain activity.53 In addition, replacement of
iron(II) with cobalt(II) in HPCD has been found to produce a hyperactive catecholcleaving enzyme.54 While metal substitution can be performed to some extent in
numerous 2H1C containing enzymes, retention of activity in the reconstituted enzymes
tends to fluctuate. This could be due to a combination of factors which would include the
metal ion’s radius, electronic configuration, redox potential, and coordination geometry.
Oftentimes, iron(II) is replaced by manganese(II) when substrate binding experiments are
performed, as manganese(II) doesn’t generally support oxygen activation and turnover of
the substrate, thus affording substrate binding experiments and crystal structures to be
generated in an aerobic environment. The absence of turnover in these metal replacement
situations is thought to be due to the change in redox potential of the metal ions. For
example, metal swapping in HPCD has allowed for the generation of Co-HPCD, Mn10

HPCD, and Fe-HPCD, where the difference in redox potential between the three metal
ions is approximately 1.2 V.54,55 Amazingly, this large difference does not hinder the
ability to turn over the native substrate, 3,4-dihydroxyphenylacetate. While the
coordination of the amino acid side chain residues to the metal center are thought to
modify these values, it is believed that in general, manganese possesses a redox potential
that is too high for efficient dioxygen activation reactions, and that MnHPCD and MndD
are a special case.
The fascination with non-heme iron(II) enzymes and their chemistry has spawned
research in small molecular models of the oxygenase enzymes and specifically the 2H1C
active site to elucidate structural characteristics of the metal-ligand framework and details
in the mechanisms of iron-catalyzed chemical reactions. For example, soybean
lipoxygenase (LO) contains a 3H1C coordination motif.3,6,56 Several small molecular
complexes

have

been

generated

to

mimic

the

LO

active

site,

such

as

[FeII(TNPA)(OH)(O2CR)]ClO4 (Figure 1.5).3,57 This complex provides the nitrogen
ligands and carboxylate oxygen, while providing bulky groups to sterically protect the
OH bound to the iron(III), maintaining the Fe-OH bond. This Fe-O bond distance was
found to be identical to that in the native enzyme, whereas previous complexes contained
shorter bonds to iron from all ligands.
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Figure 1.5

Soybean Lipoxygenase Active Site and Model Complex

A. The coordination environment of the soybean lipoxygenase active site. PDB: 1F8N
B. The inorganic complex synthesized to mimic the soybean lipoxygenase active site
Several successful attempts at small molecular complexes specifically targeting
the 2H1C binding mode have been generated, giving them the ability to bind in a
polydentate fashion to metal ions, and these models have been used to mimic the
chemistry of the Rieske and extradiol families of dioxygenases as well as the αKG
dependent enzymes.3,42 By making several R group substitutions to an αKG model, Que
and coworkers, and Valentine and coworkers concluded that the oxidative
decarboxylation of αKG required a nucleophilic attack of the superoxide at the ketocarbon.6,58-60 It is model complex experiments such as these that help to elucidate the
mechanistic details of enzymatic reactions.
Studies on 2H1C enzymes span several decades and include a breadth of
experimental techniques that explore the structure and function of many nonheme iron(II)
enzymes. As such, there are enzymes that exhibit model behavior for the family they
belong to. Herein, focus will remain on αKG/taurine dioxygenase, a representative
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enzyme from the αKG- dependent family of enzymes; and homoprotocatechuate 2,3dioxygenase, a member of the extradiol dioxygenase family of enzymes. We will look at
structure and thermodynamics of iron(II) binding to the 2H1C facial triad to gain insight
into what drives the metal binding process. Additionally, the thermodynamics of
substrate binding will be investigated. The substrate binding step is crucial in the
mechanistic pathway of the oxygenase enzymes, as the ligation of substrate to the iron(II)
center is what is thought to activate iron(II) towards dioxygen, affording the targeted
chemical reaction to take place.
1.2

The ring-cleaving dioxygenases
Aromatic ring structures vary in type from small single-ringed compounds to

large biopolymers such as lignin. These compounds are highly stable, due to the
delocalization of electron density in the π orbitals in the aromatic ring. As a result, many
natural and man-made products and bi-products that contain such stable rings are widely
dispersed throughout the environment and are chemically challenging to degrade. To
overcome this, many microorganisms contain enzymes that, when functioning in series,
work to decompose compounds with aromatic rings into a usable source of carbon.61 The
ring-cleaving dioxygenases are a family of enzymes that are designed to participate in
such catabolism of aromatic compounds through an oxidation reaction of a catecholate
substrate that results in ring-opened products (Figure 1.6 A).41 There are two types of
ring-cleaving dioxygenase enzymes: intradiol dioxygenases which in general, perform
ring-cleavage at the carbon-carbon bond between the hydroxyl oxygens using an iron(III)
catalytic center; and the extradiol dioxygenases which cleave the carbon-carbon bond
adjacent to the first hydroxyl oxygen group using iron(II) (Figure 1.6B).
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Figure 1.6

The Ring Cleavage Dioxygenase Reaction

A. 3,4-dihydroxyphenylacetate, the catechol substrate, and 5-carboxymethyl-2hydroxymuconic semialdehyde, the subsequent product of the ring-cleavage reaction by
homoprotocatechuate 2,3-dioxygenase.
B. Ring-cleavage occurs at the C-C bond adjacent to the hydroxyl oxygens for extradiol
dioxygenases (green), or in between the hydroxyl oxygens for intradiol dioxygenases
(red).
The extradiol dioxygenases are composed of three different subgroups based on
structural similarities, and are classified by their superfamily.41 Despite belonging to
differing subgroups there are key amino acid residues and structural features that are
conserved throughout the extradiol dioxygenases. The enzymes belonging to this class
contain multiple subunits, with one or two domains within each subunit. A sequence
alignment performed on over 30 extradiol dioxygenase enzymes showed that nine of the
amino acid residues are highly conserved within this family.62 Most notable are the two
histidines and one glutamate residues that make up the 2H1C facial triad.
A sequence alignment of five members of the vicinal oxygen chelate superfamily,
the type I extradiol dioxygenase enzymes, and the relevant portion can be seen in Figure
1.7. Represented enzymes are 2,3-dihydroxybiphenyl 1,2-dioxygenase (DHBD) from
Burkholderia sp. LB400, catechol 2,3-dioxygenase (C23O) from Pseudomonas putida
mt-2, homoprotocatechuate 2,3-dioxygenase (HPCD) from Brevibacterium fuscum, 2,314

dihydroxyphenylacetate 2,3-dioxygenase from A. globoformis (MndD), and 2,3dihydroxybiphenyl dioxygenase (BphC) from Pseudomonas sp. KKS102. These enzymes
cleave either monocyclic or bicyclic catechol substrates and have been used as models in
the development of a generalized mechanism for the ring-cleavage reaction of the
extradiol dioxygenase family.63-66

Among these five enzymes, there are 27 highly

conserved amino acid residues, and 39 additional residues that have conserved group
properties. The obvious residues are the 2H1C residues (red boxes), and a local histidine
(purple box) that is thought to provide stabilization of the substrate/enzyme complex
during the turnover of substrate.66-69 Interestingly, an active site pocket tyrosine (black
box) is also highly conserved, which participates in H-bonding with the catechol.49,70 In
addition, there is a conserved tryptophan/phenylalanine residue that sits in a key position
within the active site pocket and could play an important role in the stability of the
enzyme/substrate complex through π interactions with the catechol.
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Figure 1.7

Sequence Alignment of Extradiol Dioxygenase Enzymes

The sequences of five extradiol dioxygenase enzymes were aligned using Clustal-O
software. Amino acids of importance are labeled and descriptions can be found within the
text. 1F1V: A. globoformis 3,4-dihydroxyphenylacetate 2,3-dioxygenase (MndD);
4GHG: B. fuscum homoprotocatechuate 2,3-dioxygenase (HPCD); 2WL9: catechol 2,3dioxygenase (C23O); 1KW6: 2,3-dihydroxybiphenyl 2,3-dioxygenase (BphC); 1KMY:
2,3-dihydroxybiphenyl 1,2-dioxygenase (DHBD).
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Many of the highly conserved residues not mentioned above play roles in the
integrity of the tertiary and quaternary structures of these enzymes. For example, a
conserved proline residue is thought to link two adjoining β-strands, helping maintain the
structure of the β-sheet.62 There are a number of conserved glycine residues (Figure 1.7,
blue boxes), often paired with a leucine or less commonly with another hydrophobic side
chain residue, which serve as C-terminal end caps for the α-helices that are contained
within the enzymes. An illustration of this can be seen in Figure 1.8, where a C-terminal
cap is visible within a monomeric unit of HPCD, and key H-bonding can be shown by the
dashed lines. In many cases, the leucine residue is the last in the sequence of amino acid
residues that participates in the H-bonding network of the α-helix by forming a H-bond
between its amide nitrogen and the carbonyl oxygen of the tyrosine residue located at i4.62 The glycine residue falls directly over the end of the α-helix and contains Φ and Ψ
angles of 80.4o and 20.6o, respectively, allowing for two structural features: H-bonding
between the glycine amide nitrogen and carbonyl oxygen of a glutamine residue three
amino acids away which forms the C-terminal cap; and rotation of the proceeding
cysteine residue to allow for H-bonding between its amide nitrogen and the carbonyl
oxygen of a tyrosine located within the α-helix. These specific H-bonding features and
positioning of the conserved glycine, along with preservation of the Φ and Ψ angles can
be found in many of the α-helical caps that are buried within the enzyme.62
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Figure 1.8

C-Terminal Cap

An example of the capping of an α-helix within HPCD. Residues participating in Hbonding include: backbone contributions from leucine and tyrosine residues at 3.1 Å, the
amide nitrogen of glycine with a carboxyl oxygen of glutamate (3.0 Å), and the rotated
cysteine residue with a local tyrosine (3.0 Å). PDB: 4GHG. Image generated in PyMOL.
There are five highly conserved amino acid residues that work in conjunction with
three hydrophobic side chain residues to make up a major structural component of the
interface between the two domains (Figure 1.9). In a comparison of extradiol
dioxygenase enzymes, Eltis and Bolin postulated that a conserved proline residue sits
between two amino acid side chains of a nearby α-helix, facilitating the joining of the two
domains in BphC (Figure 1.9A).62 These amino acid residues are less than 4 Å from each
other, suggesting that H-bonding or other electrostatic interactions can take place
between these residues.48 When the same conserved residue is examined in HPCD
(Figure 1.9B), the general position of the proline relative to the side chains of the
neighboring α-helix are very similar, however differing amino acid side chains provide
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the favorable interactions between themselves and the proline residue, where the distance
between the residues is up to 2 Å greater. This could be directly due to the differing
amino acid side chains, an indirect result of the differences in crystallization between the
two proteins, or it could be due to larger changes in the tertiary structure of the enzyme
that do not allow for close contacts within this region.

Figure 1.9

Conserved Domain Interface

A. The conserved proline residue and amino acid side chains of favorable contacts that
hold the two domains together in BphC. PDB: 1KW6. This structure is nearly identical in
all extradiol dioxygenases.
B. The conserved proline residue and amino acid side chains providing favorable contacts
that hold the two domains together in HPCD. PDB: 4GHG. Images generated in PyMOL.
Some of the remaining conserved residues not mentioned above are located at
positions along the outside of the monomeric unit. Because the majority of these enzymes
exist in tetrameric form, the conserved residues in this region could serve the purpose of
stabilizing the quaternary structure at the monomeric unit interfaces. This theory is
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examined in HPCD (Figure 1.10). When looking at the position of the highly conserved
tryptophan295, it becomes apparent that there are two possibilities for H-bonding with
local amino acid side chains: arginine247, which stems from the same monomeric unit
(unit A); and aspartate230 from monomeric unit C. Indeed, aspartate230 is also
conserved across the extradiol dioxygenases, and the arginine residue is conserved
insofar that a positively charged side chain rests in the same location across this family of
enzymes.

Figure 1.10

Interface Between Monomeric Units

An illustration of conserved amino acid side chains and their role in holding together
individual monomeric units of HPCD. Trp295 and Asp230 adjoin monomeric units A and
C. Arg247 likely H-bonds with Trp295 through backbone atoms, and could also interact
with Asp230. PDB: 4GHG. Image generated in PyMOL.
The globular structure of the ring-cleaving dioxygenases must be very important
to their overall function, as Nature has preserved many of the structural features as
mentioned above.71,72 Most of the intradiol and extradiol dioxygenase enzymes contain
two or more subunits, and are commonly found as homodimers and homotetramers. 41
Within a single subunit, the type I extradiol dioxygenases contain four copies of a βαβββ
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structural motif.73 Two of the copies are found within the first domain (N-terminal
domain), and two in the catalytically active second domain (C-terminal domain). Two
βαβββ motifs are held together through hydrophobic interactions, which are no doubt the
product of the interactions between the conserved hydrophobic amino acid residues. This
forms a funnel 20 Å in length in each of the domains.71 The C-terminal domain funnel
holds the nonheme iron(II) ion, which is ligated to the 2H1C facial triad. His155 is found
in the first β strand of the third copy of the βαβββ motif which lies within the C-terminal
domain, whereas His214 and Glu267 are located in the first and fourth β strands,
respectively, of the fourth copy of the βαβββ motif. An example of this metal ligation in
the βαβββ motif can be found in Figure 1.11.
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Figure 1.11

Metal Ligation Motif

An illustration of the 4 copies of the βαβββ motif, two in the N-terminal domain, and two
in the C-terminal domain. His155 lies within the first β-sheet in the third copy of the
βαβββ motif, whereas His214 and Glu267 are found within the fourth copy of the motif.
These three ligands make up the 2H1C facial triad to bind the iron(II) metal ion. The
illustration is adapted from reference 17
HPCD and MndD, which have 83% sequence identity, have an additional domain
that is approximately 70 amino acids long at the C-terminal end.41,74 This domain is
referred to as the lid domain, where a conserved arginine (Arg243) is located. The
arginine is speculated to interact with the R group on the distal end of the catechol,
closing the active site pocket during catalysis.49 This gives both the C-terminal domain
and the lid domain active roles in the turnover of substrate. The function of the Nterminal domain is not known, however some speculate that at one time it may have
served as an additional active site.41,75 A view of all three domains in HPCD can be seen
in Figure 1.12.
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Figure 1.12

Three Domain Monomer

The monomeric unit of HPCD showing the N-terminal domain (blue), C-terminal
domain (green) which holds the 2H1C motif, and the lid domain (yellow). PDB: 4GHG.
Image generated in PyMOL.

The mechanism for ring-cleavage reactions has been developed through extensive
spectroscopic, computational, and kinetic analyses of several enzymes within the
extradiol dioxygenase family (Figure 1.13).40,49,63-66,76-79 The first step is bidentate
binding of the catechol substrate to the iron(II) center (Figure 1.13A).49 Here, the
hydroxyl oxygens of the catechol bind trans to the histidine residues of the 2H1C,
displacing three solvent molecules and creating a five-coordinate iron(II). This allows for
binding of dioxygen to the open coordination site. The iron(II) center gives an electron to
dioxygen, creating an iron(III)-superoxo (Fe3+-O2•-) intermediate species (Figure 1.13B).
When this occurs, an electron is passed from the catechol to the iron(III), creating a
semiquinone-iron(II)- superoxo species (SQ•-Fe2+-O2•-). The SQ•-Fe2+-O2•- species is
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advantageous because the semiquinone is a free radical and highly unstable, making it
prone to a radical based attack. However, the active intermediate that attacks the substrate
is thought to be highly dependent on the electronic properties of the substituent on the
catechol. This has been demonstrated in QM/MM experiments where the active form for
the cleavage of the native substrate is the SQ•-Fe2+-O2•- species, whereas the active form
for the substrate surrogate 4-nitrocatechol is the Fe3+-O2•- species.80,81 It is thought that
this is due to the electron withdrawing properties of the nitro group substituent. For
clarity, Figure 1.13C has been labeled with an asterisk to represent either intermediate
state of the active site complex. Regardless of active intermediate, it is the superoxo
species that attacks the C3 carbon of the substrate, producing an alkylperoxo
intermediate, as seen in Figure 1.13D. The rate determining step of O−O bond cleavage
immediately follows to create a lactone (Figure 1.13E). The incorporation of the second
oxygen occurs through hydrolysis of the lactone ring, creating the ring-opened product.
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Figure 1.13

Proposed Mechanism of the Extradiol Dioxygenases

The proposed mechanism above illustrates the important intermediate states in the
turnover of catechols. Step C can be in either of two active states, depending on the
electronic properties of the catechol substituent: either a semiquinone-iron(II)- superoxo
species as is the case for the native substrate, or iron(III)-superoxo species for electronwithdrawing substituents like 4NC. Step F shows the point of C-C cleavage with a red
line. Details of the mechanism can be found within the text.
Questions have been raised about the protonation state of the catechol because the
anionic character of the substrate can lower the oxidation-reduction potential of
iron(III)/iron(II). It has been hypothesized that the catechol exists in monoanionic form to
produce a neutral charge on the iron(II): a negative charge coming from the glutamate
residue in the 2H1C, and the second negative charge stemming from the bound substrate
to balance the 2+ charge on the iron ion. However, the iron(II) is thought to be
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responsible for shifting the electron density from the catechol to the bound dioxygen; 82
this creates a more electron-dense region in the iron(II)-substrate complex and may
facilitate metal oxidation and electron donation to dioxygen. Computational studies on
substrate binding to an extradiol dioxygenase were performed to find out which
protonation state was energetically favorable, by using iron(II) complexed with two
imidazoles and one formate to represent the 2H1C.79 The protonation state of the
substrate was determined by studying all possible protonation states, and selecting the
state with the lowest free energy. Interestingly, the dianionic binding mode was
calculated to be a mere 1.8 kcal/mol higher in energy than the monoanionic form.
Although the monoanionic protonation state is favored, this energy difference is quite
small in the context of the entire ring-opening mechanism and realistically either state
could occur in solution.
In 2002, Vaillancourt et al. provided evidence towards a monoanionic
substrate/enzyme complex through the use of resonance raman spectroscopy.63 UV and
resonance raman data were collected for control experiments involving the various
protonated forms of 2,3-dihydroxybiphenyl, and were compared to substrate-bound
DHBD data. This comparison showed that the spectral shifts occurring in the
substrate/enzyme complex were highly similar to that of the monoanionic substrate
control. However, a study performed in 2005 by the same group indicated that a dianionic
substrate bound to iron in the absence of a greater enzyme structure is blue shifted
significantly, resulting in a λmax within one nanometer of the free monoanion.64 Could this
be the case for DHBD as well? Because this additional set of control experiments was not
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performed in the DHBD study, it is hard to definitively assign whether or not the bound
substrate exists as a mono- or dianion.
Some of the substrate/enzyme complexes of the extradiol dioxygenases have been
crystallized to reveal asymmetric binding of the catechol to the iron(II) center.49,83 This is
thought to be due to the monoanionic state of the catechol. However, in HPCD two
substrates

are

often

used

to

study

the

ring-opening

mechanism:

3,4-

dihydroxyphenylacetate (HPCA), the native substrate for HPCD; and 4-nitrocatechol
(4NC), a substrate surrogate used because of its spectroscopic sensitivity to different
ionization states and environments. In this case, it was found that 4NC exists as a dianion
when bound to the enzyme where the native substrate is still thought to bind in a
monoanionic fashion.84 Interestingly, the crystal structures of these two substrate/enzyme
complexes overlay almost perfectly, suggesting that the asymmetric binding may not be
due to the protonation state of the catechol (Figure 1.14).
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Figure 1.14

Active Site Overlay of 4NC and HPCA

The active site pocket of HPCD with substrates bound to the iron(II) center. Amino acid
side chains important in stabilizing the substrate-enzyme complex are labeled. The native
substrate (HPCA) is colored pink, and 4NC is colored yellow. PDB: 4GHG and 4GHH.
Image generated in PyMOL.
Taking a closer look at the crystal structures of the extradiol dioxygenase
enzymes, it is evident that the highly conserved tyrosine residue (Tyr250 in DHBD,
Tyr257 in HPCD and MndD) forms a H-bond with what is thought to be the deprotonated
hydroxyl oxygen.49 Perhaps the interaction between this residue and the substrate is
responsible for this asymmetry at the active site.85 Horsman et al. reported asymmetry in
the dianionic bound substrate of C23O, a ferric center that ring-opens catechol through an
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intradiol mechanism.64 It was proposed that the asymmetry was due to a conserved
arginine residue that was hypothesized to H-bond with the deprotonated hydroxyl oxygen
of the catechol substrate. The position and role of the arginine residue is analogous to the
tyrosine residue found in HPCD. In a study published in 2012, structural and kinetic
experiments were performed on a Tyr257Phe mutant of HPCD to provide insight into the
role of the tyrosine in the enzymatic turnover of substrate.83,86 When tyrosine was
replaced with phenylalanine, the rate at which the enzyme turned over the substrate was
drastically slowed, indicating that the tyrosine could be involved in stabilizing the
substrate for nucleophilic attack by the oxygen. The crystal structure of the complex
revealed no significant changes in the asymmetry of the catechol binding upon Tyr
substitution. However the differences between the bond lengths of the two iron(II)oxygen bonds is 0.1 Å, a distance that seems insignificant for a crystal structure of 1.9 Å
resolution.
Intriguingly, Arg243 is poised on the lid domain to provide stability to the
catechol substituent through a salt bridge.85 In the case of the native substrate of HPCD,
the carboxylic acid tail is positioned within proximity to Arg243 for salt bridge
formation. When the surrogate 4NC is used, distances between the catechol tail and the
amino acid side chain become too great to support these interactions. Yet the enzyme
contains another arginine residue (Arg293) within the lid domain that is much closer in
distance to the 4NC tail and can provide a similar interaction as Arg243, supplying
stabilization at the distal end of the iron(II)-substrate complex.49
The catecholate is not the only substrate that necessitates stabilization at the active
site to ensure efficient turnover. Supporting the dioxygen-iron(II) complex is requisite for
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oxygen incorporation into the catechol. Extensive analysis of His200, a highly conserved,
essential amino acid residue is also thought to be a contributor to the turnover of
catechols through stabilization of the bound dioxygen. It was originally thought that this
histidine acted as a local base for the deprotonation of the catechol. However,
experiments using mutant forms of His200 in HPCD showed that regardless of the amino
acid side chain in the 200 position, the protonation state and activity of the enzyme
remained the same.87 Further analysis of the second half of the reaction; when dioxygen
is activated and the ring is cleaved, showed slowing in several of the intermediate steps
supporting the notion that the His200 residue is partially responsible for the stability of
bound dioxygen and could act as an acid catalyst during ring cleavage. In addition, the
turnover of substrate in the absence of His200 is thought to be dependent on the inductive
effects of the substituent bound to the catechol ring, as the electron-withdrawing
substituent resulted in incomplete turnover. This further supports the idea that His200
contributes to the stabilization of dioxygen bound to the ferrous center. It is clear to see
that the thorough explorations of the local amino acids provide insight into the roles of
the side chain residues in support of efficient turnover.
Iron(II) is at the center of the ring-opening reaction taking place within the
extradiol dioxygenase enzymes, making its role in catalysis well-defined. What’s
fascinating is how Nature selects a distinctive transition metal ion for these enzymes and
still provides catalysis for the ring-opening reaction. More specifically, the extradiol
dioxygenase HPCD (B. fuscum) retains activity when iron(II) is replaced by
manganese(II) or cobalt(II), and the homologous protein MndD (A. globoformis) can
also exchange iron(II) for its native manganese(II) ion. These are atypical cases of metal
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exchange; most enzymes cannot support activity when iron(II) is replaced with
manganese(II). Furthermore, metal insertion for these enzymes is not trivial; metalsubstituted HPCDs are generated by limiting divalent metal ions available during
recombinant expression, and it is believed that metal insertion takes place during protein
folding. Experiments involving the removal of metal ions by chelation in vitro are
unsuccessful at yielding the apoprotein. One successful attempt has been reported in the
case of MndD where exhaustive dialysis using a chaotrope and a chelator yielded MndD
apoprotein, but no metal replacement was reported.74
It appears that Nature’s design of HPCD allows for perfect tuning of the
reduction/oxidation potential of iron(II), allowing O2 to be activated easily. However, this
does not explain why manganese(II) and cobalt(II) can be substituted into the active site
and generate product with high efficiency. Redox potentials for manganese(II) (1.51 V)
and cobalt(II) (1.92 V) are more than double the potential of iron(II) (0.77 V), making
them poor candidates for the activation of O2. Moreover, the electron transfer process
would be slower for these metal ions, yet overall rate for the ring cleavage reaction is
equal to or greater than the FeHPCD catalyst.88 Is the mechanism for the metalsubstituted HPCDs different than the native, FeHPCD? The question remains as to
whether or not the metal-substituted HPCDs are able to undergo a M3+-superoxo
transition species. If the globular structure supports this ability, then oxidation of the
substrate should occur readily by the stronger manganese(III) and cobalt(III) oxidizing
agents. Studies on the various metal-substituted HPCDs and MndDs show that CoHPCD
binds O2 less tightly than the Mn- and Fe-HPCDs, and the manganese(II) form of HPCD
and MndD are unable to turn over 4NC.53,55 Moreover, theoretical studies of MndD and
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manganese(II) substituted HPCD suggest that the manganese(II) form of the enzymes
undergoes a spin transition after dioxygen binding to yield a more favorable reaction
coordinate.65,85 This could suggest subtle electronic differences within the mechanism of
ring-cleavage for these systems.
In this collection of work, the thermodynamic properties of the native substrate,
HPCA, binding to FeHPCD and MnHPCD are presented and compared to the binding of
the substrate surrogate, 4NC, in both enzymatic systems. Insights into the driving force
behind substrate binding and its mechanistic implications are discussed in great detail to
help discern the role of the substrate and the role of the metal center during the enzymecatalyzed, ring-cleavage reaction.
1.3

The α-ketoglutarate-dependent enzymes
A variety of enzymes pertinent to human health catalyze oxidation reactions

within the cell. These reactions range from synthesis to degradation, desaturation to ring
expansion, and many involve four electron oxidation mechanisms.89,90 Some of these
enzymes are equipped to handle the four electron oxidation reaction independently,
where the substrate can provide the reducing equivalents necessary for O2 activation,
such as the ring closure reaction of the linear tripeptide ACV by IPNS to create
isopenicillin N.91 Conversely, there are many enzymes that require the use of a
cosubstrate as an additional reducing agent, which is coupled with the oxidation of the
substrate. In many cases, α-ketoglutarate is oxidatively decarboxylated concomitantly
with the oxidation of primary substrate to yield the targeted product (succinate) and
carbon dioxide. Energetically, this is a clever approach by living systems to utilize the
decarboxylation reaction to drive the oxidation reactions.
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α-Ketoglutarate (αKG) is one of the intermediate compounds in the process of
oxidation of acetyl-CoA, also known as the citric acid cycle, a central oxidation reaction
of living systems.18,92 This essential nine step reaction scheme provides electrons that
ultimately produce ATP, the main energy source in cells (Figure 1.15). Many anabolic
and catabolic processes occur within cells that either utilize these intermediates as
reactants or generate them as products, sustaining the cycle and leaving an efficient
pathway of metabolism that can still supply electrons for ATP production. For example,
acetyl-CoA can be drawn off for the production of cholesterol, and succinyl-CoA is used
for the synthesis of porphyrin and heme. On the contrary, decomposition of the amino
acids aspartate, phenylalanine, and tyrosine result in the production of fumarate, which
can be found as the intermediate in the sixth step of the cycle.
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Figure 1.15

The Citric Acid Cycle

In this abbreviated version of the citric acid cycle (CAC), the nine steps are labeled with
additional synthesis and degradation reactions shown by green dashed arrows. αKetoglutarate and succinate are of major interest, where they participate as reactants and
products, respectively, of the αKG-dependent enzymes.18,93
Interestingly, the first three reactions in the citric acid cycle are highly favorable
in free energy (ΔG ≥ -20 kcal/mol) and are irreversible. Perhaps it is the irreversible
nature of these steps in the citric acid cycle that allow for enough production of αKG for
it to be efficiently utilized in the various αKG-dependent reactions throughout the cell.
Eloquently enough, this cosubstrate of oxidation reactions is oxidatively decarboxylated
to produce succinate, which can then re-enter the citric acid cycle as intermediate step
five. This is just one small example of Nature’s highly orchestrated oxidation reactions,
where the entire cell works in concert to efficiently maintain life.
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T h e α K G- d e p e n d e nt e n z y m es all us e α K G i n t h e s a m e m a n n er, m a n y of w hi c h
utili z e a n o n h e m e ir o n(II) i o n c o or di n at e d t o t h e 2 H 1 C f a ci al tri a d. M or e o v er, t his f a mil y
of e n z y m es c at al y z es t h eir r es p e cti v e r e a cti o ns usi n g t h e s a m e g e n er al m e c h a nis m w hi c h
c a n b e f o u n d i n Fi g ur e 1. 1 6. 8, 9 4 ,9 5 T h e r esti n g st at e of t h e e n z y m e ( A) c o nt ai ns a
m o n o n u cl e ar n o n h e m e ir o n(II) c e nt er li g at e d t o t w o histi di n e r esi d u es, a c ar b o x yli c a ci d
m oi et y fr o m a n as p art at e/ gl ut a m at e r esi d u e, a n d t hr e e w at er m ol e c ul es.

T h e first st e p

i n v ol v es t h e bi n di n g of α K G t o t h e m et al c e nt er i n a bi d e nt at e f as hi o n ( B), w hi c h h as
b e e n s u g g est e d t o o c c ur st e p wis e: i niti al bi n di n g of t h e c ar b o x yl at e o x y g e n, f oll o w e d b y
c h el ati o n t o t h e ir o n(II) i o n t hr o u g h t h e k et o n e, w hi c h pr o d u c es a n a bs or b a n c e b a n d at
5 3 0 n m fr o m m et al- t o-li g a n d c h ar g e-tr a nsf er tr a nsiti o ns a n d a visi bl e lil a c- c ol or w h e n
c o n c e ntr ati o ns of t h e s u bstr at e/ e n z y m e c o m pl e x ar e hi g h. 9 6 Bi n di n g of t h e α K G r el e as es
t w o w at er m ol e c ul es, m ai nt ai ni n g a si x- c o or di n at e ir o n(II) c e nt er. N e xt, t h e pri m ar y
s u bstr at e bi n ds i n pr o xi mit y t o t h e m et al c e nt er ( C), i n d u ci n g a l oss of t h e r e m ai ni n g
c o or di n at e d w at er m ol e c ul e a n d cr e ati n g a fi v e- c o or di n at e ir o n c e nt er w hi c h h as b e e n
st u di e d i n c o m p ut ati o n al c h e mistr y a n d c h ar a ct eri z e d b y M öss b a u er, m a g n eti c cir c ul ar
di c hr ois m, a n d

U V- vis s p e ctr os c o pi c t e c h ni q u es. 3 8 ,3 9 ,5 2 ,9 0 ,9 6 T his s u g g ests t h e fi v e

c o or di n at e ir o n c e nt er h as a n o p e n sit e f or di o x y g e n t o bi n d, gi vi n g t h e e n z y m e c o ntr ol
o v er di o x y g e n r e a cti o ns t hr o u g h a s u bstr at e-i n d u c e d o p e ni n g of a c o or di n ati o n sit e.
I ntri g ui n gl y, s elf- h y dr o x yl ati o n c a n o c c ur i n s o m e α K G- d e p e n d e nt e n z y m es, al b eit a
m u c h sl o w er a b err a nt o xi d ati o n t h a n t h e t ar g et e d r e a cti o n.

9 7 ,9 8

I n t h e c as e of α K G/t a uri n e

di o x y g e n as e ( T a u D), o xi d ati o n of a l o c al t yr osi n e r esi d u e r es ults i n a n ir o n- c at e c h ol at e
c o m pl e x, c a usi n g i n a cti v ati o n of t h e e n z y m e.
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Figure 1.16

The General Mechanism of the αKG-Dependent Enzymes94

Dioxygen binding and activation creates an Iron(III)-superoxo complex (D) that
attacks the C2 position of αKG.38,99 The new iron(IV)-alkylperoxo intermediate is shortlived (E), where the decarboxylation of αKG results in a monodentate-bound succinate
and creation of an iron(IV)-oxo intermediate (F).11,89,100-103 This high valent intermediate
then abstracts a hydrogen atom from the primary substrate, initiating the oxidation of the
substrate by

creating a substrate radical and an Fe(III)-OH complex (G).11,102 The

subsequent step includes an oxygen rebound mechanism that hydroxylates the substrate
(H), creating an unstable intermediate which spontaneously breaks down to form the
primary products for the reaction, leading to regeneration of the ferrous catalytic center.
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By and large, the αKG dependent enzymes contain physical characteristics that
afford them the ability to catalyze chemical reactions using the same general
mechanism.17 More specifically, many of these enzymes belong to the cupin family
which contains a characteristic cupin barrel around the active site cavity (Figure 1.17).
This barrel is commonly made up of two β-sheets, often consisting of four individual βstrands per sheet. The 2H1C ligands are found within two β-strands of the same β-sheet,
and the secondary sphere amino acids that help support the enzyme/substrate complex are
contained within the β-strands on the opposing β-sheet. This is illustrated in Figure 1.18
(top), and is translated to the crystal structure image for the hypoxia-inducible factor
prolyl hydroxylase 2 (PHD2), Figure 1.18 (bottom).17,104 Curiously, the model system for
the αKG-dependent hydroxylase enzymes, TauD, only contains seven β-sheets yet still
maintains the cupin barrel structure and catalytic function of a hydroxylase enzyme
(Figure 1.19).47
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Figure 1.17

The Cupin Barrel

The cupin barrel is made up of eight β-strands arranged into two β-sheets opposing each
other, with the iron(II) ion in the center. This barrel is a characteristic structural feature of
the cupin superfamily of enzymes, to which many of the αKG-dependent enzymes
belong. The enzyme represented above is the factor-inhibiting hypoxia-inducible factor 1
(FIH), a major enzyme in the hypoxic response pathway. PDB file: 1MZE. Image
generated in PyMOL.105
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Figure 1.18

Cupin Barrel Conserved Topology Diagram for an αKG-Dependent
Enzyme

Top: The αKG-dependent enzymes that contain a cupin barrel carry their 2H1C amino
acid residues on one β-sheet (yellow circles) and conserved positions of important
secondary sphere residues aiding in stabilization of the substrate-enzyme complex on the
opposing β-sheet (red circles). Diagram was adapted from reference 23.
Bottom: The translation of the topology diagram to the crystal structure of prolyl 4hydroxylase (PHD2) with αKG bound (in white). The 2H1C residues (yellow) clearly
originate from one β-sheet, while the secondary sphere residues (red) for stabilization of
the primary substrate (not shown) are on the opposing β-sheet, creating the cupin barrel.
PDB file: 3OUJ. Image generated in PyMOL.104
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Figure 1.19

The Monomeric Unit of TauD

The cupin barrel of the monomeric unit of TauD is shown with the 2H1C ligands in
yellow. TauD has contains only seven β-strands, but still retains the cupin barrel shape, a
common modification among the cupin superfamily. PDB file: 1OS7. Image generated in
PyMOL.106

The 2H1C ligands are sequenced in the primary structure of the enzyme so as to
come together and coordinate to the iron(II) metal ion in a facial orientation that supports
the activation of molecular oxygen (His1-X-Asp/Glu-Xn-His2).17,90 When αKG is bound,
subtle differences in the stereochemistry of the iron(II) center can dictate the chemical
reaction that takes place. Michael Knapp and coworkers refer to this stereochemistry as
“anti” and “clock” orientation, although it has also been referred to as “in-line” and “offline” binding respectively, which can be seen in Figure 1.20.17,90 In the case of “in-line”
binding, αKG binds opposite His1 and the Asp/Glu residue, leaving the remaining
coordination site in proximity to the primary substrate binding location. In the “off-line”
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coordination, αKG binds opposite His2 and the carboxylate ligand, resulting in the sixth
coordination site to be positioned away from the primary substrate. It has been observed
that some enzymes, such as AlkB and ABH3, can alternate between the two isomers as
evidenced in crystal structures where the enzymes have been isolated in both forms.98
This suggests that there could be some conformational flexibility in the ligand binding
mode for these enzymes, perhaps deactivating it when the alternative binding mode
exists. Another such example is clavaminate synthase (CAS), where the active site
complex was found to rearrange during turnover of the substrate, a conformational
change referred to as the “ferryl flip.”107 In this case, it is hypothesized that after
oxidative decarboxylation of αKG and CO2 is released, the ferryl intermediate undergoes
rearrangement through a possible oxygen-water exchange and positions the oxygen to
favor reaction with the primary substrate.
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Figure 1.20

In-Line versus Off-Line Binding Modes at the Active Site

An illustration of the proximity of primary substrate (R-H) to the coordination site for
dioxygen binding (red). In-line binding is clearly the favored binding mode for efficiency
of hydrogen atom abstraction. The off-line binding mode has been demonstrated to
undergo rearrangement to facilitate oxidation of the primary substrate. Image was
adapted from reference 17.

Regardless of the positioning of the open coordination site, it is imperative that
the carboxylic acid moiety of αKG binds trans to the His1 ligand of the iron(II) center.
This is supported by computational studies and experimental evidence of {FeNO}7 and
{FeNO}8 complexes, respectively.99 In these studies, it was found that the α-keto acid has
much more favorable interactions between its lowest unoccupied molecular orbital and
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the highest occupied molecular orbital of the bound dioxygen. Furthermore, the acid
moiety is able to act as an electron donor to the metal center, facilitating the charge
transfer to the bound dioxygen and increasing the ferric character of the metal center.
These interactions go hand in hand to support the formation of an iron(IV)- peroxo bridge
that leads to decarboxylation of the αKG.
Another feature of the carboxylate substituent of the aspartate residue is its ability
to H-bond with a coordinated water molecule. This H-bonding interaction provides
stability for the enzyme, as observed for TauD. Once again, density functional theory
predicts that as the primary substrate taurine binds, the coordinated water molecule is lost
giving the aspartate residue opportunity to rotate downwards and away from the
coordination site. The presence of this single water molecule is calculated to provide
approximately 10 kcal/mol in stability for the αKG-enzyme complex, indicating its
importance to the stability of the of the six-coordinate system. 39
Questions arise amid the discussion of the endogenous ligands that are
responsible for metal chelation. Are the 2H1C amino acid residues used solely for their
ability to chelate iron(II), or do the histidine and carboxylate side chains specifically
provide electronic stability for the complex to perform catalytic funciton? Insight into the
roles of the endogenous chelating residues was provided by an in-depth study of metal
ligand substitution to TauD.46 Mutations were made to each of the three endogenous
ligands involved in the 2H1C, and many of these mutations were shown to merely
provide metal chelation within the enzyme. However, a select few mutations were found
to support some catalysis of the active site. More specifically, substitution of Asp101 or
His255 to a glutamate residue, or glutamine substitution at His255 resulted in an active
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form of the enzyme. Curiously, the Asp101Glu substitution caused rate constants for the
reaction to drop, and resulted in minimal accumulation of intermediates observed by UVvis spectroscopy. It is thought that this could be due to the lengthening of the chain by
one carbon atom, thus inducing a shift in the spacial position or subtle change in
geometry of the metal center. However, no structural data is available to support this
notion. Interestingly enough, the need for the carboxylate moiety at this particular
location was maintained, since substitution to other side chain functional groups showed
loss of activity. Moreover, the active His255 mutants also contained an amide nitrogen or
carboxylate group, thus establishing the necessity for the electronic effects that these
particular atoms provide. What’s more fascinating was the discovery that no substitution
for His99 could produce catalytic activity, suggesting that this residue is highly
conserved among the αKG-dependent dioxygenases to specifically support and direct the
catalytic function of the enzyme.
The specific amino acid sequence and the stereochemistry at the iron center that
results from αKG binding provide facilitation for the reaction to take place. However,
there are many secondary sphere residues that also play integral roles in stabilizing the
substrate-enzyme ternary and quaternary complexes to support catalysis. Many of the
supporting secondary sphere side chain residues are not highly conserved across the
αKG-dependent enzymes, but their location in the globular structure is conserved to
specific positions on two β-strands.17 This could be to accommodate support for the
differing substrates across the cupin barrel family. The roles of the secondary sphere
residues are illustrated here based on extensive work performed on TauD.

44

αKG uses two amino acid side chains to help stabilize the molecule when it is
bound to the iron(II) center (Figure 1.21). On the distal end, favorable H-bonding is
formed with Thr126, along with a salt bridge to Arg266 from the C5 carboxylate of αKG,
as observed from crystal structures of the substrate-enzyme complex.47,106 This seems
rather simplistic in comparison to the concerted efforts of several amino acid side chains
that help stabilize and guide taurine towards hydroxylation, and is no doubt due to the
fact that taurine does not bind directly to the metal center. Thus, stabilization of both the
sulfonate and amine ends of the taurine molecule require stabilization to facilitate the
mechanism of TauD.

Figure 1.21

αKG and Stabilizing Secondary Sphere Resides

Alpha-ketoglutarate is stabilized on the distal end by forming a salt bridge with Arg266
(2.7 Å), and a H-bond with Thr126 (2.7 Å). PDB File: 1OS7. Image generated in
PyMOL.
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The taurine sulfonate group appears to possess favorable interactions with the side
chains of Arg270 and His70, and H-bonds with the amide backbone of a local valine
residue (Figure 1.22A).47,108 Mutations at Arg270 and His70 result in the loss of substrate
binding, indicating their importance in the substrate-enzyme complex. Detailed substrate
studies using stopped-flow UV-vis spectroscopy indicate that the sulfonate group of the
primary substrate is also crucial for substrate binding in this pocket.96 Here, studies of the
native activity indicate a perturbation in the UV-vis signature when taurine is bound.
However, this perturbation is lost when the sulfonate group is replaced by a phosphonate
moiety by using the substrate analog 2-aminoethylphosphonate. In addition, replacement
of the amino group of taurine produced the same results, indicating that the favorable
interactions with the amino group are also essential to substrate binding and turnover.
These particular interactions include a possible H-bonding interaction with Asn95, and
two water molecules which stabilize the distorted tetrahedral geometry of the amino
functional group of taurine (Figure 1.22B).106,108 A more likely scenario for the role of
Asn95 could involve H-bonding interactions with the water molecules, providing a
network of H-bonds to stabilize the substrate-enzyme complex.
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Figure 1.22

Stabilization of Taurine in the Active Site Pocket

A. Sulfonate interactions of taurine with (blue residues) His70 (2.7 Å), Arg270 (3.3 Å),
and the backbone of Val102 (2.7 Å). The 2H1C residues appear in green. Blue spheres
are local water molecules that are thought to be important in stabilization of taurine.
B. Amine group stabilization by two local water molecules (blue spheres, 3.1 and 2.4 Å).
It is suggested that Asn95 oxygen H-bonds with the amine hydrogen atom, a distance of
3.2 Å.
C. The hydrophobic region of the active site pocket (yellow residues) that stabilize C1
and C2 of taurine. Glu94 H-bonds with the hydroxide of Tyr73, positioning the tyrosine
ring to interact with C2 of taurine. On the opposite site of taurine, two phenylalanine
residues are poised to hold the aliphatic portion in place. PDB file: 1OS7. Image
generated in PyMOL.

Although both ends of the primary substrate taurine are stabilized in the active
site pocket of TauD, additional support is necessary for the abstraction of a hydrogen
atom by the iron(IV)-oxo intermediate.102,109,110 Several residues work together to
position the aliphatic chain of the taurine molecule (Figure 1.22C). For example, Hbonding between the side chains of Asp94 and Tyr73 position the aromatic ring of the
tyrosine residue to interact with the C2 atom of taurine. From the opposing side, two
phenylalanine side chains (Phe159 and Phe206) are in proximity to the taurine C1 and C2
atoms.106 Collectively, these provide a network of interactions that cradle the primary
substrate in the active site pocket and position the C2 atom towards the open coordination
site of the iron(IV)-oxo species.109
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In support of the crystallographic evidence, McCusker and Klinman reported a
detailed study on the H-atom abstraction as a function of the size of the active site cavity
in TauD.110 Site-specific mutagenesis was performed on phenylalanine159, maintaining
the hydrophobic nature of the side chain, but leaving the side chain length as a variable.
As the side chain length decreased, the kcat for the reaction decreased producing less
sulfite per oxygen molecule bound until the oxidative decarboxylation and the oxidation
of taurine become uncoupled (as evidenced by the kinetic isotope effect using deuterated
taurine experiments).109,110 This suggests that the phenylalanine side chains are providing
stability to the substrate-enzyme complex by supporting the primary substrate in the
pocket, and increasing the physical space between the residues and the substrate allows
for more flexibility in the positioning of taurine. If the taurine molecule is not correctly
oriented in space by these residues, H-atom abstraction cannot take place.
Hausinger and coworkers also support this notion of proximity and positioning of
taurine in the active site cavity through innovative studies involving electron spin echo
envelope modulation (ESEEM) spectroscopy.111,112 By using detailed analyses of ESEEM
data collected on substrate-bound TauD and related {FeNO}7 complexes paired with
DFT studies of the substrate-active site complex, it was determined that the hydrogen of
the C1 atom of taurine sits approximately 2.5 Å from the iron(IV)-oxo and the bond angle
for the atoms is approximately 135o (Figure 1.23). In addition, the bond angle from the
hydrogen atom to the C2 atom with respect to the oxygen is approximately 173o. These
results are in great agreement with the DFT calculations, which indicate the ideal distance
and angle for hydrogen atom abstraction. Furthermore, the distances between atoms
corroborate the previously published crystal structures.47,106 These novel ideas highlight
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the importance of the supporting secondary sphere residues and more specifically the
hydrophobic residues within the active site cavity in positioning the taurine molecule for
the oxidation reaction.

Figure 1.23

ESEEM Angles of Taurine Position

ESEEM data estimate the position of taurine based on the angles about the hydrogen
atom. Results were calculated to be in excellent agreement with DFT data, and indicate
that the hydrogen atom is at the proper angle and distance (2.6 Å) for hydrogen atom
abstraction to occur by the iron(IV)-oxo.111
Because the binding of taurine within the active site pocket requires the
supporting interactions of many side chain residues, a conformational change is invoked
during the binding process. Moreover, this conformational change appears to only allow
partial occupation of the substrate within the dimeric unit of the enzyme, as observed in
the crystal structure of substrates bound to the TauD enzyme in the absence of
dioxygen.106 In a careful analysis of two monomers of TauD; one occupied with taurine
and the other not, a shift in the position of a random coil and helix within the monomers
was observed (Figure 1.24). More specifically, when taurine is not present, the hydrogen
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bonding network holding the active site cavity closed is disrupted and causes a higher
degree of flexibility in the random coil region. However, this would expose the
hydrophobic residues located within the helix to the solvent. In order to prevent this from
occurring, the alpha helix undergoes a conformational change to a 310 helix, sheltering
the hydrophobic residues from water (Figure 1.25).

Figure 1.24

Structural Overlay of TauD with and without Taurine Bound

The Overlay of the two TauD globular structures; one with taurine bound in the active
site pocket (purple) and the other without (pink), illustrate the movement of the random
coil region and the α-helix when the hydrophobic contacts are lost. PDB files: 1OS7 and
1OTJ. Image generated in Accelerys Discovery Studio.106
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Figure 1.25

Helix Structural Changes Upon Taurine Binding

A. The common α-helical structure that results when taurine is bound in the active site
cavity. PDB file: 1OS7.
B. The 310 helix that is the result of the loss of the hydrophobic interactions within the
active site cavity when taurine is absent. Interestingly, the PyMOL software cannot
recognize the 310 helix, and generates the cartoon structure as a random coil. PDB file:
1OTJ. Images generated in PyMOL.
It is apparent that the secondary sphere residues within these enzymes play a
major supporting role in positioning and stabilizing the substrates for efficient chemical
reaction, and collectively work to produce a globular structure capable of the dynamic
movements necessary to protect the integrity of the active site pocket. Additionally, it is
evident that the iron(II) metal center plays a vital role in the catalysis provided by the
αKG-dependent enzymes, as we have seen by the various oxidation states necessary to
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support the turnover of substrates. Moreover, this iron(II) ion is absolutely necessary to
provide catalysis as indicated by metal substitution experiments,52 which can only be
supported by the 2H1C facial triad binding motif.46 Collectively, these features of the
αKG-dependent enzymes are Nature’s eloquent way of providing a breadth of chemistry
using dioxygen as a substrate.
In this work, focus will remain on the model αKG-dependent system TauD, and
the extradiol dioxygenase HPCD. These two enzymes have proven to be the paradigm
systems for their respective families of enzymes through detailed structural and
spectroscopic studies described above. Herein, we use these model systems to elucidate
the thermodynamic driving forces behind metal ion and substrate binding to the 2H1C
through the use of isothermal titration calorimetry.
Specifically, we target the TauD metal ion binding site because of the labile
nature of the iron(II) ion, affording us the ability to both directly reconstitute TauD
apoprotein with iron(II), and remove the metal ion through EDTA chelation. The
deconvolution of the complex equilibria taking place within these reactions is presented,
demonstrating how these values are obtained. The thermodynamic data obtained, and its
relevance to nonheme iron(II) enzymes are discussed.
Substrate binding in HPCD is examined in detail using isothermal titration
calorimetric techniques, and the thermodynamic driving forces behind this process are
determined. In the case of substrate binding to the 2H1C, we are most particularly
interested in the roles of the metal ion and substrate molecule during the binding reaction.
Factors such as the ionization state of the substrate, the electronic effects of the catechol
substituent, and the redox potential of the divalent metal ion are considered in the context
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of the thermodynamic properties of the substrate binding event, and discussions of how
these factors may play a role in the binding process are discussed. Our findings from
these studies contribute greatly to the energetics of the reaction mechanism, and help to
explain why these iron(II)-catalyzed dioxygen reactions are so favorable.
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CHAPTER II
NATIVE SUBSTRATE BINDING TO AN EXTRADIOL DIOXYGENASE

2.1

Introduction
Aromatic compounds found in the environment originate from a variety of man-

made and natural materials such as quinones, flavonoids, and lignin.1 These compounds
have the potential to be great sources of carbon; however they are incredibly stable due to
the resonance effects of the aromatic rings they contain. Many bacterial species have
overcome this hurdle by affording themselves the ability to break down aromatic
compounds and sequester the carbon through aerobic and anaerobic enzymatic
pathways.1-3
The extradiol dioxygenases are a family of metalloenzymes that catalyze the key
ring-opening step associated with aerobic bacterial degradation pathways for both single
and multi-ring aromatic compounds.4,5 These enzymes function by exploiting an active
site containing a mononuclear nonheme iron binding motif termed the 2-His-1carboxylate facial triad (2H1C), which has been identified as a common platform for
biological activation and utilization of dioxygen.6-9 In this motif, the iron(II) center adapts
an octahedral coordination environment with two histidine and one glutamate side chain
residues occupying one face of the octahedron, leaving three adjacent sites open for
substrate and oxygen coordination. It is here that the catechol family of substrates can
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bind in a bidentate fashion, leaving one open coordination site where dioxygen can be
activated.
The generalized mechanism of the extradiol dioxygenases is based on
spectroscopic, structural, and computational analyses of several members of the
dioxygenase family.4,10-17 This mechanism encompasses the 2H1C metal ligation motif,
and several secondary sphere residues that are highly conserved across the extradiol
dioxygenase family of enzymes which are thought to participate in the turnover of
substrate.4,18 Subtle differences in the active site cavity are what allow for the wide
diversity of catechol substrates for each individualized enzyme-catalyzed reaction.19
Homoprotocatechuate 2,3-dioxygenase (HPCD) is a member of the extradiol
dioxygenase

family

dihydroxyphenylactate

and

catalyzes

(HPCA)

to

the

ring

cleavage

reaction

of

3,4-

cis,trans-5-carboxymethyl-2-hydroxymuconic

semialdehyde (5CHMSA) (Scheme 2.1).18 Computational studies of the native reaction
indicate that when the native substrate binds in a bidentate fashion and dioxygen is
activated, the complex goes through a key semiquinone-iron(II)-superoxo intermediate
before the substrate is ring-opened to form the product.20,21 Kinetic measurements of the
turnover of HPCA by HPCD show that HPCD has high specificity for the native
substrate, where kcat is observed to be approximately 10 s-1, when following the product
chromophore (λmax = 380 at pH 8.0).10 Additionally, many computational studies on the
reaction of HPCA with HPCD have been performed starting at the substrate-enzyme
complex, in an effort to elucidate the energetic pathway of dioxygen activation and ringopening in such systems.20-24 With directed focus on the steps specifically involving
dioxygen, the fundamental process of substrate binding has been heavily overlooked,
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although it is thought to be the key step in the initiation of dioxygen binding and
activation. In fact, it was not until 2010 that a detailed analysis of how substrates bind to
the type I extradiol dioxygenase enzymes was released.19 In general, it is known that the
substrates bind in a bidentate fashion to the iron(II) metal center, and it has been
hypothesized that the catechol species is bound as a monoanion. This is supported by the
notion that the substrate-enzyme complex is charge stabilized through the positively
charged iron(II) center, and negatively charged carboxylate and catecholate ligands.21
Additionally, spectroscopic evidence of a monoanionic binding mode has been reported;
crystallographic data show catechol binding in an asymmetric fashion, which is thought
to be due to the monoanionic nature of the substrate (Figure 2.1),25,26 and studies
surrounding Raman spectroscopy techniques indicate the possibility of a proton that
remains on the bound catechol.14 However the idea of a dianionic substrate bound to the
metal center would favor a more electron-rich iron(II) environment, allowing for easier
activation of dioxygen.21,27 Furthermore, computational analyses report the free energies
for a bound monoanionic catechol versus a bound dianion are virtually indistinguishable,
leading to the possibility of catechol substrates losing both hydroxyl protons during the
binding event.21
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Scheme 2.1 The HPCD-Catalyzed Reaction
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Figure 2.1

Asymmetric Substrate Binding in HPCD

This image depicts HPCA (white) binding to the iron(II) center (orange) of HPCD. Slight
differences in the bond lengths of O1-iron(II) and O2-iron(II) can be seen. These subtle
variations in length are attributed to the differences in protonation state between the two
hydroxyl groups.11,25,26 The 2H1C amino acid residues are shown in green, with
secondary sphere residues that are thought to help stabilize the substrate-enzyme
complex, in blue. PDB image: 1QOC. Image generated in PyMOL.
In this study, the thermodynamic properties associated with the binding event of
the native substrate, HPCA, to HPCD are experimentally determined using isothermal
titration calorimetry (ITC), and the number of protons released by the system is reported
in the context of the mechanism of the extradiol dioxygenase enzymes.28
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2.2

Materials and methods

2.2.1

General procedures for the thermodynamic observation of substrate
binding to HPCD
All solutions and media were made using 18 MΩ water filtered using a Millipore

Ultrapurification system. All media, buffers, and salts purchased were of the highest
grade available and used as received. HPCA (3,4-dihydroxyphenylacetate) was purchased
through Alfa Aesar at 99% purity and used as received.
2.2.2

Overexpression and purification of homoprotocatechuate 2,3-dioxygenase
Overexpresssion and purification was performed following previously reported

procedures with modification.29 Briefly, 250 mL LB media containing 100 μg/mL
ampicillin were inoculated with E. coli BL21(DE3) cells containing the HPCD vector
[pYZW204] and grown overnight at 37o C with gentle shaking (approximately 150 rpm).
This culture was then used to inoculate 4 x 1 L flasks of LB media with 100 μg/mL
ampicillin and were grown to an OD600 ~ 0.6, at which point they were induced with
isopropyl-β-D-thiogalactoside (IPTG). Cultures were allowed to grow for an additional 39 hours and then cells were harvested by centrifugation at 5,000 rpm and frozen until
needed.
Purification was performed on a DEAE Strong Anion Exchange column using
Fast Protein Liquid Chromatography (FPLC), where active fractions were collected and
concentrated with buffer exchange to a low salt buffer at pH 7.2. Size Exclusion
Chromatography was used as needed, dependent upon the separation of species within
the anion exchange column (Figure 2.2). SDS-PAGE gel electrophoresis was performed
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to determine the purity of the protein samples (approximately 40 kDa monomeric unit).
Figure 2.3 illustrates the protein sample purity post FPLC.

Figure 2.2

FPLC Chromatogram

The chromatogram shown is for the purification of HPCD on a size exclusion resin. The
protein was initially purified on an anion exchange resin using FPLC, and further purified
using size exclusion only when necessary.
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Figure 2.3

Purity of HPCD by SDS-PAGE Gel Electrophoresis

Samples of purified HPCD from six different cell growths were run on SDS-PAGE gel
electrophoresis. A single band can be seen in each of the six lanes, indicating a highly
purified protein sample. The ladder can be seen in the far right lane.
2.2.3

Isothermal titration calorimetry (ITC)
The HPCD samples for ITC were prepared using the following procedures.28

HPCD (approx. 200 μM) samples were dialyzed twice against 1 L of a 25 mM buffer pH
7.2 for 3 hours each, and then dialyzed a third time overnight. The concentration of
HPCD was then determined spectroscopically (ε280 nm = 36,220 M-1 cm-1) and transferred
to a septum sealed vial. HPCA solutions were prepared by dissolving the HPCA solid
sample in the dialysate buffer at a concentration of 2.0 mM. All solutions were septumsealed and made anaerobically by purging with argon. The MicroCal ITC instrumentation
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was sealed in an anaerobic chamber (Plaslabs) with a constant dinitrogen flow during the
course of the experiment. Data were collected at 25 oC typically using 5 μL injections of
HPCA over a 4 s period, with 300 s spacing between injections to allow full return of
power to baseline. Data was analyzed using Origin software (OriginLabs), and CHASM
software developed in the laboratory of Ed Lewis (Mississippi State University), which
use a nonlinear least-squares fitting model to fit the heats per injection to a one-site
binding equation.30 HPCA binding to HPCD was performed in three different Good’s
buffers. Experiments were replicated at a minimum of twice, however most experiments
were repeated three to four times.
2.2.4

ITC analysis
ITC is used to directly measure the heat associated with a binding event: typically

a small ligand (metal ion or substrate) is titrated into the macromolecule (protein or
DNA), and the output measurement is the power needed to maintain constant temperature
in the ITC with respect to the reference cell.31 Integration of the raw heats yields the
direct measurement of heat of binding for the reaction, or ΔH. The mole ratio and binding
equilibrium are also directly obtained from one experiment, allowing for calculation of
Gibbs free energy (ΔG) and entropy (ΔS) for the system using the following
thermodynamic equations:
ΔG = - RT ln (K)

Eqn 2.1

ΔG = ΔH – TΔS

Eqn 2.2

Oftentimes during a chemical binding experiment, protons are either released or
consumed by the system. These protons are regulated by the buffer to maintain the pH.
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During this buffer ionization event, a discernable heat of ionization is produced that is
well quantified at specific pH values.32 Therefore, we can exploit this additional buffer
heat of ionization (ΔHionization) in ITC analysis to calculate the number of protons released
or consumed by the following mathematical relationship:33
ΔHobs = ΔHbinding + np(ΔHionization)

Eqn 2.3

where ΔHobs is the observed thermodynamic value measured directly from the
ITC, ΔHbinding is the binding enthalpy for the substrate binding reaction, and np is the
number of protons released to the bulk solution. This linear relationship can be obtained
by performing the binding reaction in various buffers and plotting the ΔHionization against
ΔHobs, where the slope is equal to np. Additionally, the y-intercept yields the ΔHbinding for
the reaction, which is independent of the buffer. For this set of binding experiments, a
variety of six different buffers were chosen, however only three were used in the analysis
of the enthalpy of binding for the reaction. The buffer choice and supporting data will be
discussed in a subsequent chapter.
2.3

Results
The raw heats and integrated isotherms for the binding reaction of HPCA to

HPCD in MOPS, HEPES, and PIPES buffers can be seen in Figure 2.4. All raw heats
were baseline subtracted and integrated to yield the binding isotherm for each reaction.
Enzyme concentrations were adjusted to reflect the occupation of iron(II) in the active
site, and the data are described by a one-site binding equilibrium where one HPCA
molecule binds per monomeric unit of HPCD. The observed thermodynamic values for
the binding reaction in each buffer can be found in Table 2.1. When these values are
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plotted against the ΔHionization, a linear relationship becomes clear (Figure 2.5). The
ΔHbinding for the reaction, independent of the ionization of the buffer, is -16.9 kcal/mol, as
indicated by the y-intercept, and 2.6 protons are released during the binding reaction.

Figure 2.4

Raw Heats and Integrated Isotherms for HPCA Binding to HPCD

A. The binding isotherm for HPCA into HPCD in HEPES buffer. Injection size was
decreased to 2 μL to obtain the full isotherm for a protein sample with low metal
incorporation.
B. The binding isotherm for HPCA into HPCD in PIPES buffer.
C. The binding isotherm for HPCA into HPCD in MOPS buffer.
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Table 2.1

Observed Thermodynamic Values for HPCA Binding to HPCD28
ΔH

K
MOPS
HEPES
PIPES
Avg.

6

1.6 (± 0.5) x 10
5

3.3 (± 0.1) x 10
6

1.2 (± 0.3) x 10

ΔH

ΔH

(kcal/mol)

(kcal/mol)

(kcal/mol)

ΔG
(kcal/mol)

-29.9 (± 2.8)

-5.04

-16.7 (± 2.8)

-8.5 (± 0.2)

8.6 (± 2.8)

-29.5 (± 0.7)

-4.86

-16.9 (± 0.7)

-7.5 (± 0.02)

9.5 (± 0.7)

-23.9 (± 1.5)

-2.68

-16.9 (± 1.5)

-8.3 (± 0.2)

8.7 (± 1.6)

-16.8 (± 0.2)

-8.1 (± 0.5)

8.93 (± 0.5)

obs

ionization

6

1.0 (± 0.6) x 10

binding

-TΔS
(kcal/mol)

The enthalpies of ionization for each buffer were used from the reported literature.32
All values were repeated in at least duplicate and errors associated with all averages are
one standard deviation from the mean.
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Figure 2.5

Enthalpy Plot for the Binding Reaction of HPCA to HPCD28

The ΔHionization was plotted against the ΔHobs for the binding reaction in each buffer. The
resulting linear relationship can be fit to the equation y = 2.56x – 16.99 with an R2 value
of 0.999.

The Gibbs free energy for the binding reaction is favorable at -8.3 kcal/mol, and is
an enthalpy driven process as indicated by the negative ΔH values. When the data are
deconvoluted for the ionization of buffer using Hess’ Law, the calculated -TΔS terms
indicate an unfavorable entropic event. Tables 2.2-2.4 give Hess’ Law for the
deconvolution of enthalpy terms in each buffer. The averaged buffer independent data
can be found in Table 2.5, and the full thermodynamic profile is seen in Figure 2.6.
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Table 2.2

Hess’ Law of the Binding Reaction in HEPES Buffer

Reaction
2.6 HEPES + 1 FeHPCD + 1.0 HPCA
1 FeHPCD-HPCA
+

HPCA + FeHPCD

2.6 HEPES-H +

HEPES-H+

H + HEPES
a

Coefficient ΔH (kcal/mol)
+

+

FeHPCD-HPCA + 2.6 H

1

- 29.5a

2.6

- 4.9b

1

- 16.9
b

Value herein is the ΔHobs taken directly from ITC measurements, and is taken from the
reported literature32.

Table 2.3

Hess’ Law of the Binding Reaction in MOPS Buffer

Reaction
2.6 MOPS + 1 FeHPCD + 1.0 HPCA
1 FeHPCD-HPCA
+

Coefficient ΔH (kcal/mol)
+

2.6 MOPS-H +

MOPS-H+

H + MOPS

+

HPCA + FeHPCD

Table 2.4

FeHPCD-HPCA + 2.6 H

- 29.9a

2.6

- 5.0 b

1

- 16.8

Hess’ Law of the Binding Reaction in PIPES Buffer

Reaction
2.6 PIPES + 1 FeHPCD + 1.0 HPCA
1 FeHPCD-HPCA
+

HPCA + FeHPCD

Coefficient ΔH (kcal/mol)
2.6 PIPES-H+ +

PIPES-H+

H + PIPES

Table 2.5

1

+

FeHPCD-HPCA + 2.6 H

1

- 23.9a

2.6

- 2.9 b

1

- 17.0

The Averaged Thermodynamic Properties for HPCA Binding

Proton Release

K

2.6 (± 0.02)

1.0 (± 0.6) x 10

ΔHbinding
6

-TΔSbinding

(kcal/mol)

ΔG
(kcal/mol)

(kcal/mol)

-16.9 (± 1.7)

-8.1 (± 0.4)

8.8 (± 0.6)
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Figure 2.6

The Thermodynamic Profile for Native Substrate Binding to HPCD

The thermodynamic profile shown above is for the binding reaction of HPCA to HPCD,
independent of the ionization of the buffer. The entropy term is reported herein as –TΔS
to provide a direct comparison to the other thermodynamic terms in kcal/mol.
2.4

Discussion
In this study, we provide the first thermodynamic data associated with the

substrate binding event to an extradiol dioxygenase enzyme.28 Our data indicate that the
bidentate binding of the catechol HPCA to the active site of HPCD is an enthalpically
driven event, at – 16.9 kcal/mol. This substrate binding equilibrium is best modeled on a
one-site event as expected when one HPCA molecule binds per monomer of HPCD.
When the substrate binds within the active site pocket, approximately 2.6 protons are
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released from the system. We attribute this to at least one full proton lost from the HPCA
bound to the iron(II) center as substrate binds in a monoanionic fashion, and an additional
1.6 protons lost from somewhere within the globular substrate-enzyme structure. There
are two likely scenarios for proton loss within the complex, which most likely originate
from the active site cavity. Firstly, reasonable candidates for the additional proton loss
could be local amino acid residues that are thought to participate in stabilization of the
substrate-enzyme complex. These include a loss of protons on the δ nitrogen of local
histidines, His200 and His248. Additionally, there is a local tyrosine residue that is
thought to H-bond with a hydroxyl oxygen of the catechol. However, the pKa of the side
chain is approximately 10.1, which may not make it a probable target for proton loss. A
more practical source of proton loss stems from the second hydroxyl proton of HPCA
when it’s bound to the metal center. It is known that the Lewis acidity of transition metals
is enhanced by the ligation mode of the 2H1C.34 Although the pKas of HPCA are 9.71
and 11.25,35 it is possible that the Lewis acidity of the metal center lowers the pKas of the
bound catechol, causing double proton loss and resulting in a dianionic bound substrate
as seen in the substrate-enzyme complex of catechol 1,2-doxygenase.34 Thus, the
additional 0.6 protons could be due to subtle changes in the pKa of a local residue to
support the H-bonding network of the newly formed substrate-enzyme complex.
Computational studies lend credibility to this idea, as there is a low energy barrier
between the monoanion and dianionic bound forms (approximately 1.8 kcal/mol).21
Overall, the binding equilibrium of 1.0 x 106 results in a favorable Gibbs free
energy term of -8.1 (± 0.4) kcal/mol, indicating that the favorable enthalpy term is offset
by a smaller, unfavorable entropy term. Moreover, the measured K value is in excellent
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agreement with the previously reported Kd value of < 2 μM.10 The unfavorable entropy
term that balances the thermodynamic parameters could arise from restricted mobility of
the substrate and the enzyme in the active site cavity, which is supported by the notion
that a C-terminal loop folds over the active site pocket and forms a lid to the cavity
during catalysis.36 This entropy term may be smaller in nature due to the proton release,
which would contribute favorably to the entropy for the system through release of
additional atoms in the system and through charge stabilization of the anionic substrate
with the positively charged divalent metal center.37
Clearly, the ionization state of the catechol plays a highly important role in the
stabilization of the substrate-enzyme complex in HPCD, through H-bonding interactions
of secondary sphere residues and the support of the one-electron redox potential of the
metal center. We believe our data is fully consistent with the notion that when the native
substrate binds in a bidentate fashion to the active site of HPCD, the pKas of the hydroxyl
groups are lowered and both protons are lost to bulk solvent leaving a dianionic substrate.
This is supported by the large exothermic enthalpy associated with substrate binding,
which must include Coulombic interactions between the dianionic substrate and the metal
center. This would further support electron transfer from the catechol to the dioxygen
when it binds, creating the semiquinone-iron(II)-superoxo intermediate species that is
capable of nucleophilic attack at the C2 atom of the catechol.
2.5

Conclusion
We have provided the first thermodynamic properties associated with substrate

binding to the extradiol dioxygenase enzyme HPCD.28 These values are the first
experimentally determined free energies that can be contributed to the computationally
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determined reaction coordinates that are missing the energy values for the key substrate
binding step.21 Our data indicate a favorable binding reaction that is enthalpically driven,
and 2.6 protons are released by the system when substrate binds. This is most consistent
with the idea that the substrate is bound as a dianion, supporting facile electron transfer
from the substrate to the dioxygen when it is bound.27 This study clearly provides new
insight into the first steps of the reaction mechanism of extradiol dioxygenases, and
warrants further study of catechol binding to these enzymes to determine the role of the
substrate and the role of the metal in the stabilization of the substrate-enzyme complex.
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CHAPTER III
ENZYME-BUFFER INTERACTIONS AND THE EFFECT ON THE ENZYMATIC
FUNCTIONS OF HPCD

3.1

Introduction
The use of buffers as a means to maintain the pH of a solution with the

expectation that the buffering compounds will be relatively inert and unreactive in
solution is one of the most common laboratory practices in biochemistry. In reality, this
is not always the case for many buffering systems.1-8 Bioinorganic complexes are
particularly sensitive to the superfluous effects of buffer compounds, and on occasion
these interactions have been ignored or misinterpreted for metalloproteins such as
homoprotocatechuate 2,3-dioxygenase (HPCD).9
HPCD is a non-heme iron(II) enzyme that catalyzes the key ring-opening step in
the degradation of aromatic compounds.10,11 In the monomeric form, HPCD is made of
two domains, where two copies of a βαβββ motif can be found per domain.12,13 It is this
motif that forms the funnel shaped active site through the hydrophobic interactions
between motifs (Figure 3.1A and B). At the center of this active site sits a six-coordinate
nonheme iron(II) ion ligated by two histidine and one glutamate residues on one face of
its octahedral coordinating sphere. These ligands make up what is referred to as the 2His-1-Carboxylate facial triad, a common metal binding motif among many of the
enzymes in the extradiol dioxygenase family (Figure 3.1C).14,15 This facial triad allows
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for binding of the substrates and dioxygen activation to occur in close proximity on the
same face of the iron(II) octahedron, resulting in efficient catalysis for the enzyme.16
Additionally, HPCD contains a loop with a conserved arginine residue which interacts
with the distal end of the substrate. This loop serves as a lid to close in the active site
when a substrate molecule is bound. HPCD functions as a homotetramer (Figure 3.2),
and initial substrate binding studies along with crystal structures of the substrate-enzyme
complex could suggest some degree of cooperativity between the four units of HPCD in
the absence of oxygen. 17,18
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Figure 3.1

Structure of HPCD

A. The βαβββ motif, of which HPCD contains multiple copies to form the active site
cavity.
B. The globular structure of the HPCD monomeric unit, which shows the N-terminal
domain (blue), the C-terminal domain (green) which holds the 2H1C facial triad, and the
lid domain (yellow).
C. The iron(II) center ligated to the 2H1C (green residues) of HPCD. The native substrate
(pink) is bound in a bidentate fashion, and the third site is coordinated by a water
molecule (blue X).

Figure 3.2

Tetrameric Form of HPCD
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In Chapter 2, we established the thermodynamic properties of native substrate
binding to HPCD.17 For these binding reactions, the heats of ionization of various
biological buffers were exploited to create a linear correlation plot of observed enthalpy
versus the enthalpy of buffer ionization.19,20 This correlation allows for the calculation of
the change in enthalpy for the binding event (ΔHbinding), which includes the displacement
of water molecules, binding of the substrate, and any structural rearrangements that may
take place. This is represented mathematically as:

ΔHobs = ΔHbinding + n(ΔHionization)

Eqn 3.1

During the data collection process, it was noted that several buffers defied the
accepted linear trend of buffer ionization against observed enthalpy. When these values
are placed on the same enthalpy plot, the differences become apparent (Figure 3.3).
Specifically, the binding reaction in ACES (N-(2-acetamido)-2-aminoethanesulfonic
acid) and potassium phosphate buffers each deviated from the trendline by approximately
9 kcal/mol (pink), while the reaction in Tris (tris-(hydroxymethyl) aminomethane) buffer
(green) was 28 kcal/mol lower in enthalpy than predicted. In all three cases, enthalpic
values for the binding reaction were lower than expected, which suggests additional
processes are occurring during the binding event in these particular buffering systems that
are unaccounted for in our simple linear relationship seen in equation 1. Our initial
hypothesis to explain this observation was that an enzyme-buffer interaction takes place
between the three above mentioned buffers and HPCD, and that this molecular
interaction must be removed before the binding reaction can occur, thus causing an
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additional endothermic process in these particular systems. Therefore, equation 1 should
contain an additional enthalpic value for these processes:
ΔHobs = ΔHbinding + n(ΔHionization) + ΔHenzyme-buffer

Eqn 3.2

In order to assess this interaction, experiments were performed using ITC kinetic
methodology, and HPLC product quantitation of time-dependent reactions in the various
buffers. These experiments were designed to determine whether the enzyme-buffer
interactions also affect the turnover of the HPCD reaction by monitoring the rate of the
reaction and the amount of product produced over time. From this information, we aim to
resolve the implications of the enzyme-buffer interactions on the thermodynamics of
substrate binding and the complete catalytic turnover of the HPCD reaction, in hopes to
uncover the nature of the enzyme-buffer interactions taking place in solution.
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Figure 3.3

Enthalpy Plot of the HPCA Binding Reaction to HPCD

The substrate binding reaction was performed in various buffers to utilize their heats of
ionization. ACES and potassium phosphate buffers (pink), lie off the line 9 kcal/mol,
while the reaction in tris buffer (green) is low by 28.3 kcal/mol. Error bars represent one
standard deviation of the mean.

3.2
3.2.1

Materials and methods
Reagents and general procedures
Reagents and buffers were the highest grade commercially available and were

used as received. Structures of the buffering molecules can be found in Figure 3.4. The
following buffers under study were used in the free acid form and dissolved in water,
after

which

the

pH

was

adjusted

to

7.2

with

NaOH:

MOPS

(3-(N-

morpholino)propanesulfonic acid), PIPES (piperazine-N,N’-bis(2-ethanesulfonic acid)),
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HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), and ACES. Tris buffer
was purchased in its free base form, dissolved in water, and pH adjusted to 7.2 with HCl.
Potassium phosphate was used in its monobasic form, dissolved in water and pH adjusted
to 7.2. All solutions and media were prepared by using 18 MΩ water purified by a
Millipore ultrapurification system. All reactions were performed at 25 oC, unless
otherwise noted.

Figure 3.4

Molecular Structures of Buffering Systems

A. Phosphate (potassium used as the counter ion)
B. ACES (N-(2-acetamido)-2-aminoethanesulfonic acid)
C. PIPES (piperazine-N,N’-bis(2-ethanesulfonic acid))
D. HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
E. MOPS (3-(N-morpholino)propanesulfonic acid)
F. Tris (tris-(hydroxymethyl) aminomethane)
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3.2.2

Overexpression and purification of HPCD
HPCD was overexpressed in E. coli BL21 (DE3) and purified as reported with

modification.21 Briefly, cells were lysed and HPCD was initially purified as previously
reported. Fractions were then collected from a diethylaminoethyl (DEAE) strong anion
exchange column and further separated using size exclusion chromatography. HPCD
relevant fractions were collected, pooled and concentrated while performing a buffer
exchange into 25 mM MOPS pH 7.2.
3.2.3

Steady-state kinetics by isothermal titration calorimetry
For

the

HPCD

catalyzed

turnover

of

HPCA

to

5-carboxymethyl-2-

hydroxymuconic semialdehyde (5CHMSA), 8 nM HPCD solutions were made in 100
mM buffers at pH 7.2. Solutions of 14 mM HPCA were made in the same 100 mM stock
solution of buffers at pH 7.2 and loaded into the ITC syringe. A single injection of 10 μL
HPCA was made into the HPCD solution in the cell, and the reaction was allowed to
proceed for 6500 seconds. Control experiments were performed where 10 μL of the 14
mM HPCA solution was titrated into buffer to account for the heat of dilution. Any heat
of dilution from the control experiments was subtracted from the relevant kinetic
experiment. Data analysis was performed using kinetic fit ITC software created in the
Lewis Biophysical Laboratory in which steady-state parameters were obtained. All
experiments were reproduced in triplicate and the reported associated error is one
standard deviation from the mean.
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3.2.4

Extraction and purification of 5CHMSA
A beaker containing 100 mL of 5 μM HPCD and 5 mM HPCA in 100 mM MOPS

buffer pH 7.2 was stirred for 48 hrs to ensure that all HPCA was converted to product.
The reaction was quenched with 3 mL of 2 N HCl and placed in a separatory funnel. 3 x
100 mL of dichloromethane (DCM) were added to the flask and gently shaken. The two
layers were allowed to separate and the DCM layer was extracted and evaporated, leaving
pure product. The product was weighed by mass difference with the flask, and placed in 3
mL of water. The characteristic UV spectrum of the product was observed, which has a
λmax of 380 nm at pH 8.0 (ε380 = 36,000 M-1 cm-1), in agreement with the literature value
for the product of the HPCD reaction.22 A pH titration was then performed on 5CHMSA
to determine the λmax at acidic pH, for use in HPLC analysis. A spectral shift to λmax of
320 nm was observed and the resultant molar absorptivity was calculated to be 13,914 M 1

cm-1. A mass spectrum was obtained for the compound and identified with a mass of

199.0214 m/z in negative mode, in excellent agreement with the [M+H]- theoretical value
(199.028 m/z), indicating successful separation of 5CHMSA.
3.2.5

High performance liquid chromatography (HPLC)
A standard line of 5CHMSA varying in concentration from 50 – 750 μM was

made in water and spiked with 30 μL of 2 N HCl. A 5CHMSA control was prepared in
25 mM MOPS and Tris buffers, pH 7.2 and also spiked with 2 N HCl for HPLC analysis.
A 1 μM HPCD sample was prepared in each buffer, and HPCA was added to the HPCD
samples for final concentration of 1 mM substrate in 1 mL total volume. The samples
were briefly vortexed and allowed to react for five minutes, at which point the samples
were spiked with 30 μL of 2 N HCl to quench the reaction. All samples and standards
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were centrifuged at 13,000 rpm for two minutes and transferred to HPLC vials. A mobile
phase of 1 % acetic acid (A) and methanol (B) was used for the elution of 5CHMSA on a
C18 column using the following gradient: 0-5 minutes 100 % A; 5-6 minutes 100-70 %
A; 6-9 minutes 70 % A; 9-10 minutes 70-0 % A; 10-11 minutes 0 % A. An injection
delay period of five minutes was used between samples to re-equilibrate the column in
100 % solvent A. The product was detected using a UV-vis diode array detector at a
wavelength of 320 nm with a reference wavelength of 600 nm. In addition, signature
spectra were collected on all chromatographic peaks as an additional positive
confirmation of the pure product. The product samples in each buffer were quantified
using the 5CHMSA standard line and compared to further support ITC kinetic analysis.
3.3
3.3.1

Results
ITC kinetics
Isothermal Titration Calorimetry (ITC) was used to follow the reaction kinetics of

HPCD to determine whether the kinetic parameters are affected by enzyme-buffer
interactions. The use of ITC allows the reaction kinetics to be monitored through the heat
produced during turnover. In a typical ITC experiment, a small molecule (substrate) is
titrated into a macromolecule (enzyme).23 As heat (Q) is produced or consumed by the
reaction, the calorimeter supplies or relinquishes power (μcal/sec) to the cell to maintain
a constant temperature. Therefore, during a reaction the change in power is a function of
the heat produced or consumed in the reaction cell (dQ/dt). Although the change in power
is due to all chemical processes on-going within the ITC cell, it is our assumption that the
dioxgyen activation and ring opening chemistry catalyzed by HPCD is the rate
determining process.
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When the zero-order rate law is applied to the turnover of HPCA by HPCD, a
steady state is reached where all of the enzyme molecules are bound to substrate. The
exothermic heat from the binding reaction is maintained due to excess substrate in
solution, where the release of ring-opened 5CHMSA is replaced by HPCA. Therefore,
when excess HPCA is titrated into a catalytic amount of HPCD and the power output is
stabilized at a reduced value and held constant over time, a steady state is observed
(Figure 3.5). This indicates a steady production of heat from the exothermic reaction in
the cell, which remains unchanged while the substrate is in excess. By letting the reaction
come to completion, dQ/dt becomes zero (i.e. returns to baseline), and the rates of
reaction are contained within this dQ/dt over the time course of the experiment (Figure
3.6). This relationship is mathematically described as:24-26
dQ/dt = dP/dt ∙ V ∙ ΔHobs

Eqn 3.3

where dP/dt is the product formation over time, V is the volume in the reaction cell, and
ΔHobs is the observed reaction enthalpy for the system, dependent on buffer ionization.
By rearranging the above equation, the rate of reaction can be determined:
Rate = dP/dt = dQ/dt ∙ 1/(V ∙ΔHobs)

Eqn 3.4

Integrating dQ/dt as a function of time for the reaction yields (ΔHobs). At the steady-state
maximum dQ/dt, a Vmax can be directly determined for the reaction. Additionally, by
utilizing various buffers and plotting the buffer ionization enthalpy (ΔHionization) against
the observed enthalpy (ΔHobs), the reaction enthalpy (ΔHrxn) can be obtained, along with
the total number of protons released/consumed by the reaction, according to the
following equation:
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ΔHobs = ΔHrxn + n(ΔHionization)

Figure 3.5

Eqn 3.5

Steady-State Kinetics by ITC

The reaction has reached steady state when the power has stabilized at a lower value with
respect to the baseline (time 0) for an exothermic reaction. It will remain at the stabilized
power until the reaction is no longer at steady state, at which point the power will return
to baseline.
The reaction enthalpy plot for the HPCD catalyzed conversion of HPCA to
5CHMSA is seen in Figure 3.7. The HPCD catalyzed steady-state reaction was carried
out in the six buffers of interest, yielding a buffer independent ΔHrxn of -72.8 ± 1.2
kcal/mol and a release of 1.7 ± 0.2 protons, which is in good agreement with the accepted
mechanism for the reaction.
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Figure 3.6

A Single Injection ITC Kinetics Experiment

This figure shows the raw heat of a single injection kinetic experiment, where the power
returns to baseline as the experiment comes to completion. The rates for the experiment
are contained within this curve.
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Figure 3.7

Reaction Enthalpy Plot for the ITC Kinetic Data

The enthalpies for the HPCA-HPCD reaction in various buffers are plotted against the
enthalpy of ionization of the buffer to yield a linear relationship, where the y-intercept
indicates the reaction enthalpy independent of the buffer (-72.8 ± 1.3 kcal/mol), and the
slope is equal to the number of protons released by the system (1.7 ± 0.2 protons).
A comparison of the raw data for the reaction in MOPS and Tris buffers (Figure
3.8), it becomes immediately apparent that the HPCD catalytic reaction is slowed in Tris
buffer, when compared to the same reaction in MOPS. Kinetic analysis of the steady
state data indicates that the Vmax for the reaction varies in the six different buffers (Table
3.1). Clearly, the reaction kinetics have the highest rates in MOPS buffer. Curiously, the
HPCD reaction in potassium phosphate, and Tris buffers have significantly lower Vmax
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values, and the ring-cleavage kinetics in the remaining three buffers fall somewhere in
the middle and are within error of each other.

Figure 3.8

Raw Heats for the Kinetic Analysis of HPCD in Two Buffers

The raw heat for the ring-opening reaction of HPCA by HPCD in 100 mM MOPS (blue)
and Tris (red) buffers, pH 7.2. It is evident that the reaction in Tris buffer takes longer to
return to baseline, suggesting a slower rate of reaction in Tris buffer.
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Table 3.1

V

max

k

cat

K

M

k /K
cat

M

Kinetic Parameters for the Ring-Opening Reaction of HPCA by HPCD
MOPS

PIPES

HEPES

ACES

Phosphate

Tris

2.77 ± 0.09

2.34 ± 0.17

1.97 ± 0.45

1.83 ± 0.16

1.75 ± 0.02

1.65 ± 0.11

336 ± 11

283 ± 19

243 ± 50

228 ± 11

215 ± 6

200 ± 13

7±2

13 ± 16

5±9

12 ± 8

9± 3

11 ± 4

5

8 x 10

5

4 x 10

5

8 x 10

5

3 x 10

5

4 x 10

5

3 x 10

The kinetic terms are reported in the following units: Vmax is in μM/min, kcat is in min1, and KM is in μM.

By plotting the data in a traditional Lineweaver-Burk plot, visualization of the
effect of the buffering environment on the catalytic activity of HPCD becomes more
apparent (Figure 3.9). Although this method is often used in more traditional kinetic
analyses, our method of Vmax determination allows for a more direct measurement of the
maximum rate which we believe to be more accurate. However, by plotting all of the
rates contained within the ITC experiment in a Lineweaver-Burk fashion, the observation
of trends in the changing Vmax and KM values becomes more obvious. From this plot, we
can see that the 1/Vmax (y-intercept) for the reaction in HEPES, ACES, phosphate, and
Tris are very similar. Moreover, the -1/KM value (x-intercept) for phosphate, HEPES, and
Tris buffers are very similar to MOPS buffer, suggesting that these buffers could be
acting as non-competitive inhibitors, as classically described by a changing Vmax while
KM is unchanged. A KI value can then be calculated using the Michaelis-Menten equation
in the presence of an inhibitor:
appVmax = (Vmax[S]) / (αKM + α’[S])
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Eqn 3.6

For non-competitive inhibitors (i.e. ACES), α = α’ and the equation can be simplified at
high concentrations of substrate to:
appVmax = Vmax/α

Eqn 3.7

α = 1 +[I]/K’I

Eqn 3.8

where:

Rearrangement of the equation results in calculation of KI:
KI = [I]/(Vmax/appVmax – 1)

Eqn 3.9

For example when we use the kinetic data collected, a KI value for Tris is calculated to be
approximately 147 mM. Other KI values can be calculated to yield a similar result in the
high mM concentration range.
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Figure 3.9

Lineweaver-Burk Plot

The Lineweaver-Burk plot allows for visualization of the change in the Vmax and KM
values, providing insight into the type of inhibitory effects the buffer may be providing.
Legend: MOPS (black), Tris (red), ACES (green), PIPES (purple), phosphate (blue), and
HEPES (orange).
3.3.2

HPLC analysis
A brief quantitation study was performed using HPLC to further support the ITC

kinetics result. A standard line of 5CHMSA was created to then assess the amount of
product formed after five minutes reaction time in both MOPS and Tris buffers. The
excellent linearity of the standard line yielded an R2 value of 0.9994 (Figure 3.10), and
gave means to quantify the reaction product by integration of the chromatographic peak
at an elution time of 7.8 minutes. Additionally, a UV-vis signature spectrum from 200 –
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500 nm was collected on the chromatographic peak, providing a second means of
identification for 5CHMSA.

Figure 3.10

5CHMSA Standard Line for the Quantitation of Reaction Product

The Standard line ranged in concentration from 50 – 750 μM 5CHMSA in water. Elution
of 5CHMSA from the HPLC column occurred at approximately 7.8 minutes. A plot of
the peak area against the standard concentration provided a linear relationship in which to
quantify reaction products in MOPS and tris buffers.
Control samples 100 μM 5CHMSA in each buffer were separated by HPLC and
analyzed to ensure that the peak areas and the resulting calculated concentrations were
identical in each buffering system, and that the buffers were not forming complexes with
the product, effectively lowering the molar extinction coefficient of the product as
suggested in previous reports.9 The results of this analysis yielded an average peak area
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for the controls of 3217.9 ± 123.1, which corresponds to an average concentration of 97.7
± 11 μM across the buffers tested. A representative overlay of the 100 μM controls in
Tris and MOPS buffers can be seen in Figure 3.11A.

Figure 3.11

HPLC Data for the Separation and Detection of 5CHMSA

A. An overlay trace of a 100 μM 5CHMSA control in MOPS (red) and Tris (blue)
buffers.
B. The UV-vis signature spectrum of the 5CHMSA standard (red) against the reference
(blue).
C. The elution peak of 5CHMSA from the catalytic reaction by HPCD in MOPS (red)
and Tris (blue) buffers. The reaction was allowed to proceed for 5 minutes and quenched
with 2 N HCl to denature the enzyme.
The HPLC chromatogram of 5CHMSA for the reaction that was quenched after
five minutes clearly shows a difference in the amount of product produced for the
reaction in MOPS and Tris buffers (Figure 3.11C.) Calculation of the concentration based
on the 5CHMSA standard line indicates that after five minutes, 204.1 ± 23.6 μM was
produced from the reaction in MOPS buffer, while the reaction in Tris buffer only
produced 130.6 ± 4.3 μM. This indicates that the reaction is dramatically slowed in Tris
buffer. Varying concentrations of 5CHMSA were produced for the reaction in the
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additional buffers (data not shown), which corroborates with the kinetic data obtained by
ITC.
3.4

Discussion
The use of buffering systems in biochemical reactions is necessary and routine for

the study of biological macromolecules in vitro. These buffering systems maintain the pH
of the reaction solution where the buffering capacity is imperative in the realm of
biochemical experiments; as the stability and reactivity of most enzymes are pH
dependent. However, over the years it has been demonstrated that this central function of
buffers is not necessarily the only reaction they perform in solution.1,2,4-7 For example,
several inorganic salts (e.g. phosphate buffers) can have an effect on the conformational
stability of an enzyme or protein, which has led to the increased usage of Good’s
buffering systems.5 These commonplace zwitterionic buffers were developed to be highly
soluble in water and have low solubility in organic solvents.27-29 In addition to these
properties, Good’s buffers were considered to be relatively inert substances when used
within the range of 10-50 mM, due to the bulky tertiary amines that limit the formation of
ion complexes in solution. It has been shown however, that seventeen of the twenty
Good’s buffers form complexes with metal ions.2 Analogously, one of the most
commonly used biological buffers, Tris serves as a suitable ligand for metal complexes. 7
This is of great interest when studying metalloproteins, regardless of whether the metal
ion serves as a structural or catalytic site. Interestingly, metal complexation is not the
only interaction taking place in solution. It has also been shown that several common
biochemical assays are greatly affected by buffering system choice.8 While enzymebuffer interactions are notoriously difficult to quantify, these data are an indication of the
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complex interactions that can occur in solution between the buffer system and the
biological macromolecule under study. In this report, we recount the effects of several
buffering systems on the structure and function of homoprotocatechuate 2,3-dioxygenase,
in an attempt to deconvolute the thermodynamics and steady-state kinetics of substrate
binding and turnover related to homoprotocatechuate 2,3-dioxygenase, where buffer
effects play a role in the observed values.
Previously, we reported the thermodynamic parameters of native substrate (3,4dihydroxyphenylacetic acid, HPCA) binding to HPCD by isothermal titration calorimetry
(ITC).17 These studies were performed by exploiting the heats of ionization of various
buffers, lending insight into the number of protons released from the system during the
binding event. The buffering systems chosen for these binding experiments were based
upon their commonplace use in the laboratory and their heats of ionization, which
provided a broad range of ionization energies. However, during the course of substrate
binding studies, additional endothermic enthalpies were observed in three of the buffering
systems, defying the predicted linear trend. Specifically, the ΔHbinding measured for these
substrate binding reactions in ACES, potassium phosphate, and Tris buffers were
observed to deviate from the linear trendline by up to 28 kcal/mol, a significant enthalpic
penalty for these substrate binding events.
In order to assess this interaction, our intentions were to observe any changes in
structure and stability, as well as determine whether the rate of the catalytic reaction by
HPCD was also affected by the enzyme-buffer interactions. For this purpose, we
employed a method utilizing ITC to monitor steady state kinetics of the turnover of the
native substrate HPCA with HPCD. This method has been well established as a practical
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measurement of steady state kinetics for various systems, and offers a more sensitive
approach to studying kinetics with systems at low (nM) concentrations.24,25,30 The steady
state kinetic parameters of the turnover of HPCA by HPCD have been reported by Groce
et al., in MOPS buffer at pH 8.0, and by Emerson et al. in MOPS buffer at pH 7.5 31,32
However, the spectrum of the 5CHMSA product changes with pH and requires
adjustments to the molar extinction coefficient dependent on the pH of the reaction.
Additionally, Whiting et al. reported a change in extinction coefficient of 5CHMSA when
reactions in MOPS and tris were compared.9 This idea is contradictory to our HPLC
analysis that indicates there is no significant complexation of any buffer with the product,
as the UV spectrum is identical to pure 5CHMSA, and the control samples contained
highly similar concentrations of 5CHMSA based on peak area.
The common practice of measuring Michaelis-Menten kinetics by spectroscopy is
limited in that the reported Vmax is a theoretical value based on data fitting, and not a true,
directly measured term. While employing the ideas of Lineweaver-Burk plots provide
means of obtaining the value for Vmax, the Lineweaver-Burk can supply large error in the
estimates of the linear slope at low concentrations of substrate, giving values that may be
falsely high and thus reducing the accuracy of calculating Vmax. By using ITC methods
for kinetic analysis two benefits arise; the heat of reaction is monitored and observation
of the reaction is no longer restricted by its chromophores, and by saturating the enzyme
with substrate to subsequently produce saturation in the heat provides a direct
measurement of the reaction at steady state (no linear fitting of the data is needed).
The kinetic parameters obtained by ITC are in agreement with the findings
presented in previously published experimentation of Emerson et al. and Groce et al. In
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both cases, the kinetic analyses were performed in MOPS buffer at higher pH using
spectroscopic techniques, and it was found that the optimum pH for the reaction is at pH
8.0. Experiments performed at pH 8.0 have the highest turnover of substrate (kcat = 600
min-1),31 whereas the experiments performed at pH 7.8 report a kcat value of 470 min-1,32
illustrating the reduction in speed at lower pH. Our experiments resulted in a kcat value of
336 min-1 in MOPS buffer at pH 7.2, following this trend.
Interestingly, the Vmax and subsequent calculation of kcat for HPCD does
drastically change in phosphate and Tris buffers, in direct agreement with our
thermodynamic ITC binding data that suggests an additional process taking place during
the binding event. Using the Lineweaver-Burk plot to analyze the kinetic data, it becomes
visually obvious that some of the buffering systems could be acting as weak, noncompetitive or uncompetitive inhibitors. Structurally speaking, the Good’s buffers used in
these experiments all contain either a piperazine or morpholine ring (Figure 3.4). ACES,
along with Tris contain primary amines in their structures, allowing them to be privy to
various molecular interactions with the enzyme. In addition, Tris is a known strong metal
binding ligand, while potassium phosphate has been implicated in binding with arginine
and lysine residues, which could be crucial to the function of the lid domain which
contains an arginine residue suspected of providing favorable contacts with the bound
substrate.3,5,7 It could then be inferred that for the monitoring of the catalytic reaction of
HPCD in vitro, Good’s buffers containing the piperazine or morpholine ring structures
(such as PIPES, HEPES, and MOPS) may be more inert, and less likely to participate in
enzyme-buffer interactions, which makes them more suitable for use in the binding
studies of HPCD.
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By performing experiments on the steady-state kinetics of HPCD using ITC, the
ΔHobs was also obtained in each of the buffering systems. When these enthalpies are
plotted against the ΔHionization, a correlation graph is obtained and linearly fit by equation
seven. From this, we obtained a ΔHrxn of -72.8 ± 1.3 kcal/mol. The ΔHbinding for the
binding reaction of HPCA to HPCD was reported to be -16.9 kcal/mol, leaving -55.9
kcal/mol of enthalpic energy for O2 binding and activation, incorporation into the ring,
ring cleavage, and product release. Additionally, we observe 1.7 protons released from
the turnover reaction. This proton loss is in agreement with our reported reaction
mechanism, where both protons on the catechol substrate are lost during substrate
binding and prior to O2 binding, and the resulting muconic semialdehyde species is then
released to the bulk solvent and re-protonated.17 The additional loss of 0.7 protons could
be attributed to the partial loss of a proton from the formation of an enolate complex in
the 5CHMSA product. Curiously, when the ΔHbinding plot (Figure 3.3) is compared to the
ΔHrxn plot (Figure 3.7), no additional endothermic processes are noticeable in the ΔHrxn
plot, where the ΔHobs in various buffers all fall within 3 kcal/mol of the linear fit. This
could be due to a reversible process, such as a specific enzyme-buffer interaction that is
removed for the binding reaction to take place (i.e. within the active site). When oxygen
is present and turnover results, completion of the reaction allows for the enzyme-buffer
interaction to once again occur, which would be in line with the assessment that the
buffers are providing a non-competitive inhibition binding interaction. This interaction
would be equal in enthalpic magnitude but opposite in sign, thus unobservable during
reaction enthalpy measurements but visible through kinetic studies. However, when just
the binding reaction is performed in the absence of O2, only the removal of the enzyme105

buffer interaction is observed with substrate binding, since the turnover reaction is not
allowed to proceed. Therefore, the additional enthalpic process convolutes the ΔHbinding
data.
If these interactions are truly non-competitive in nature, we can assess the KI for
each of the buffers, which indicates high concentration (> 100 mM) values. While large
KI values are generally disregarded as inconsequential, they become relevant and of
concern when dealing with buffer systems, as many biochemical reactions are performed
in buffer systems with concentrations within a range of 10-150 mM. In some cases buffer
concentrations can be many orders of magnitude higher than the biological molecules
under consideration.
3.5

Conclusion
To summarize, the data shown here suggest that buffering systems can be non-

innocent in enzyme reactions by providing weak enzyme-buffer interactions that can
convolute both thermodynamic and steady-state kinetic properties. In HPCD, these
interactions seem to stem from non-specific interactions that are hindering the substrate
binding process. These buffers, namely Tris, phosphate, and ACES, should be avoided
when studying substrate binding reactions of HPCD. Conversely, the favored buffers for
use with HPCD are the Good’s buffers that contain morpholine or piperazine rings, and
are limited in the number of primary amines. While the avoidance of buffers limits the
number of buffering systems that can be utilized for proton release analysis, it ultimately
allows for a more accurate determination of the enthalpy of substrate binding.
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CHAPTER IV
CALORIMETRIC INVESTIGATIONS OF SUBSTRATE COORDINATION TO THE
METAL SITE IN AN EXTRADIOL DIOXYGENASE

4.1

Introduction
The 2-His-1-carboxylate-containing enzymes have a preserved metal-ligand

binding motif for the support of oxygen activation reactions with high efficiency, and
many of these enzymes utilize a very similar catalytic reaction mechanism. 1-8 In this
mechanism, the iron(II) center activates dioxygen to create an iron(III)-superoxo species
that can then attack the substrate also bound to the metal center (Figure 4.1). In the case
of the extradiol dioxygenase enzymes, the substrate itself has been found to influence the
intermediate state of the substrate-enzyme complex; the well-studied 4-nitrocatechol
(4NC) substrate surrogate for homoprotocatechuate 2,3-dioxygenase (HPCD) is believed
to form the iron(III)-superoxo intermediate species, while the native substrate 3,4dihydroxyphenylacetate (HPCA) bound complex goes through a semiquinone-iron(II)superoxo intermediate species which subtly changes the mechanistic route that the
enzyme takes during catalysis.9,10 Many studies have been performed on the substrate
surrogate 4NC with HPCD, helping to elucidate the reaction mechanism for the
enzyme.11-14 4NC contains a nitro substituent on the aromatic ring, which provides it with
spectroscopic sensitivity to the ionization state and subtle changes in its environment
(Figure 4.2). Kinetic studies have shown that the enzymatic activity is slower with 4NC
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in comparison to HPCA, and it has been thought that this is due to the dianionic
ionization state when bound to the enzyme, as well as the electron withdrawing effects of
the substituent on 4NC.11,15

Figure 4.1

Substrate Binding Steps in the Extradiol Dioxygenase Mechanism

The first steps in substrate binding to the active site center are shown for HPCD.
Substrate binding induces the loss of the three coordinated water molecules and the two
protons from the catechol. O2 binding and activation occurs to produce an iron(III)superoxo intermediate species that can then attack the bound substrate.

Figure 4.2

Commonly Studied Catechol Substrates of HPCD

The native substrate 3,4-dihydroxyphenylacetate (left) and 4-nitrocatechol (right) are the
two highly studied substrates for HPCD. 4-nitrocatechol is spectroscopically sensitive
and has been used to elucidate the mechanism of HPCD.7,11
The divalent metal ion at the active site also plays a major role in substrate
binding and oxygen activation, which is based on its reduction-oxidation potential.16
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These enzymes have been evolved with a native non-heme iron(II) ion resting in the
active site center, where it is thought that the endogenous ligands help lower the redox
potential of the metal ion in comparison to aqueous iron(II) ions. Binding of anionic
substrates further lowers this potential, allowing for reactivity with dioxygen.17 For many
enzymes in the non-heme iron(II) family, efforts have been made to study the
coordination chemistry using a metal-substitution experiments where the iron(II) ion is
replaced with a non-native, divalent metal ion. For example, the iron(II) metal center of
AlkB which catalyzes demethylation of DNA bases, has been replaced by the divalent
metal ions copper, cobalt, and manganese.18,19 It is the manganese(II) form that is often
used to trap substrate-enzyme complexes due to its redox stability under aerobic
conditions. In parallel, the iron(II) center of IPNS has also been replaced with
manganese(II) in efforts to obtain a crystal structure of the enzyme.20 On the contrary,
upon replacing the iron(II) center of quercetin 2,3-dioxygenase (QDO) with
manganese(II), a modulation of its activity was reported.21 In most cases, the substitution
of manganese(II) into the active site center results in drastically reduced activity of the
enzyme or complete inhibition. This has proven to be the case for the ABH family of
enzymes, α-ketoglutarate dependent taurine dioxygenase and urease, as well as the AlkB
and QDO enzymes.19,22,23
In very few cases, manganese(II) has been found to replace iron(II) and still
facilitate dioxygen activation. Moreover, some naturally-occurring manganese(II)dependent enzymes have been found to be analogous to their iron(II) containing
counterparts. For example, manganese(II)-dependent superoxide dismutases have been
reported, as well as a thermally stable 2,3-dihydroxylbiphenyl 1,2-dioxygenase (BphC111

JF8*) that contains manganese(II) as the native center.24-27 This enzyme is only 25%
sequence identical with the iron(II)-containing BphC-LB400 extradiol dioxygenase
enzyme, but is able to catalyze the same ring-opening event. Another such case in the
extradiol dioxygenase family is the manganese(II)-dependent 2,3-dioxygenase (MndD),
which is 83% sequence identical to HPCD and can perform the same ring-cleavage on
HPCA.28,29 Metal swapping of HPCD and MndD have shown that these two enzymes can
perform the same catalytic turnover at very similar rates, with either iron(II) or
manganese(II) at the active site center.30 Additionally, computational studies have
supported the notion that the two metallated forms of HPCD and MndD follow the same
catalytic mechanism to produce the ring-cleaved product.31
In this study, we probe the role of the metal and the substrate to determine the
thermodynamic driving forces behind substrate binding to HPCD. The native substrate
binding reaction is compared to the binding of the substrate analog (4NC) in both the
native form of HPCD (FeHPCD) and the manganese(II)-substituted form (MnHPCD).
These data are collectively compared and contrasted to provide insight into the energetics
of the binding reaction and how it might influence the ability for catalytic turnover in this
extradiol dioxygenase enzyme.
4.2
4.2.1

Materials and methods
Reagents and general procedures
All reagents and buffers were of the highest grade available and used as received.

All solutions and media were prepared in 18 MΩ water purified through a Millipore
filtration system.
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4.2.2

Overexpression and purification of Fe(II) and Mn(II) HPCD
Overexpression and purification of HPCD was performed as previously described

with modification.32 Cell cultures were grown in M9 minimal media and spiked with 25
mg/L of the metal salt two hours before induction. HPCD was purified using a DEAE
strong anion exchange resin by FPLC and further purified on a size exclusion column to
achieve > 95 % purity. Fractions were pooled and concentrated in 25 mM MOPS buffer
at pH 7.2. The metal content of HPCD was analyzed on a Perkin Elmer ELAN(II)-DRC
inductively coupled plasma mass spectrometer (ICPMS).
4.2.3

Isothermal titration calorimetry
Protein samples for ITC were prepared as follows: The concentration of isolated

HPCD was determined spectroscopically (FeHPCD ε280
ε280

nm

nm

= 36220 M-1 cm-1, MnHPCD

= 54000 M-1 cm-1) and diluted to a final concentration of 0.2 mM. HPCD was

dialyzed against a 1 L of 25 mM buffer (3-morpholinopropane-1-sulfonic acid (MOPS),
1,4-piperazinediethanesulfonic

acid

(PIPES),

2-[4-(2-hydroxyethyl)piperazin-1-

ul]ethanesulfonic acid (HEPES), or cacodylate) at pH 7.2 for 16 hours. HPCA (Alfa
Aesar) and 4NC (Sigma Aldrich) solutions were prepared with the matched dialysis
buffer at a concentration of 2.0 mM. All solutions were made anaerobic by purging with
Ar. The MicroCal VP-ITC instrumentation was sealed in an anaerobic chamber (Plaslabs)
with constant nitrogen flow during the course of the experiment. Data were collected at
25 0C commonly using 3 μL injections over a 6 second period with a 300 second spacing
between injections, however adjustments to the injection parameters were made based on
metal content of the enzyme per experiment. HPCD concentration was adjusted to reflect
metal content and a mole ratio of one for the substrate binding to the enzyme monomer
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per tetrameric unit. Data was analyzed using a one site model in MicroCal data analysis
software package in Origin (OriginLabs) and using CHASM software developed in the
laboratory of Ed Lewis (Mississippi State University), which uses nonlinear least-squares
algorithms with the titrant and cell concentrations to fit the change in power per injection
with equations that correspond to an equilibrium binding model.33

Isotherms for

substrate binding to HPCD in various buffers were replicated 2-4 times and averaged.
The HPCA binding to MnHPCD experiments were performed at 1 mM MnHPCD and 20
mM HPCA in a 100 mM MOPS buffer at pH 7.2 in order to observe the full isotherm.
4.2.4

Stopped-flow UV
Proton release events during the substrate binding reactions to MnHPCD were

monitored by using well established methods reported previously.34-39 MnHPCD was
dialyzed for 16 hours in 100 mM MOPS buffer at pH 7.2. MnHPCD was then diluted to a
final concentration of 20 μM using the dialysate in the presence of 100 μM bromothymol
blue. Solutions of HPCA and 4NC were also prepared at a concentration of 20 μM with
the dialysate in the presence of the indicator dye. All solutions were made anaerobic by
purging with Ar gas. Mixing experiments were performed on a U.S.A. stopped-flow
mixing apparatus coupled to an OLIS RSM 1000 spectrophotometer, where the
absorbance at 420 nm was monitored over a time period of five minutes.
4.3

Results
ITC experiments permit the measurement of the heat associated with a binding

reaction. From one experiment the observed enthalpy, reaction stoichiometry, and
equilibrium constant for the binding reaction can be directly obtained, allowing for
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calculation of the Gibbs free energy and the change in entropy by using equations 2.1 and
2.2. Entropy data presented herein is reported in terms of –TΔS to allow for a direct
comparison to the enthalpy and Gibbs free energy (ΔG) terms.
The observed enthalpy obtained from such an experiment includes the ligand
binding reaction, solvent dissociation, and ionization of the buffer during proton release
events. Because of this coupled reaction, the buffer heats of ionization can be exploited to
acquire the number of protons released during the binding event.40 A plot of the observed
enthalpies (ΔHobs) versus the known buffer enthalpies of ionization (ΔHionization) can be
linearly fit with a y-intercept reflecting the enthalpy for the binding reaction (ΔHbinding)
independent of the buffer ionization, and a slope equal to the number of protons (np)
released (Eqn 2.3). This ΔHbinding term can then be used to calculate the –TΔSbinding term.
Our ITC experiments were performed in buffers chosen for their pH range and negligible
heats of interaction with the protein itself. All experiments are baseline corrected and
background subtracted. The background can consist of heats of dilution of the substrate
and the enzyme, as well as residual heats from nonspecific interactions of substrate and
enzyme when the binding reaction is completed. Control experiments are performed to
account for any heats of dilution, and residual heats are subtracted by setting the endpoint
of the titration reaction to zero.
For the binding reaction of 4NC to FeHPCD, the raw heat was baseline corrected
and the isotherms were fit for one site binding to yield an equilibrium constant (K) of 7.7
(± 3.7) x 105, consistent with previously reported 1/Kd values, and favorable in Gibbs free
energy, where ΔG is approximately -8.0 (± 0.2) kcal/mol.15,30,32 A representative raw
heat and integrated isotherm for the binding reaction of 4NC to FeHPCD in cacodylate
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buffer is illustrated in Figure 4.3. This binding reaction was performed in two additional
buffers, and all observed values can be seen in Table 4.1. When a plot of ΔHobs against
ΔHionization is generated from the 4NC binding reaction to FeHPCD in three buffers, a best
fit line yields a slope corresponding to 1.5 (± 0.3) protons released from the system
(Figure 4.4, green line). From the proton release data, we are able to determine the
ΔHbinding in each buffering system by applying Hess’ Law and creating a thermodynamic
model accounting for the individual reactions taking place in solution. An example of this
deconvolution can be seen in Table 4.2, where the ΔHbinding is -13.7 (± 1.1) Tables 4.3 and
4.4 contain Hess’ Law calculations for 4NC binding to FeHPCD in the remaining two
buffers. Calculation of -TΔSbinding yields a value of 5.6 (± 1.3) kcal/mol which indicates
an entropically unfavorable binding event. A list of the ΔHbinding and –TΔSbinding terms for
4NC-FeHPCD in each buffer is listed in Table 4.5. Values are then averaged to give the
buffer independent thermodynamic properties for the binding reaction, where ΔHbinding is
-14.2 (± 1.1) kcal/mol and –TΔSbinding is 6.3 (± 0.9) kcal/mol (Table 4.6). Calculation of
the Gibbs free energy and entropy terms indicate that while the substrate binding reaction
of 4NC to FeHPCD is unfavorable entropically, the ΔG for the reaction is favorable,
driven by the enthalpic contributions.
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Figure 4.3

Representative Raw Heat and Integrated Isotherm for 4NC Binding to
FeHPCD

The binding reaction of 4NC to FeHPCD was performed in cacodylate buffer, pH 7.2 to
obtain the binding equilibrium, enthalpy and molar ratio for the reaction. Gibbs free
energy and entropy terms were calculated using the standard thermodynamic equations.
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Table 4.1
Buffer
HEPES
PIPES
Cacodylate

Figure 4.4

Observed Thermodynamic Parameters for 4NC Binding to FeHPCD
ΔH

ionization

(kcal/mol)
-4.86
-2.68
0.71

ΔH

obs

(kcal/mol)
-21.0 (± 1.1)
-19.0 (± 0.8)
-12.8 (± 1.5)

ΔG
(kcal/mol)

K
1.2 (± 0.9) x 10
5.3 (± 2.8) x 10

6
5

5.90 (± 0.6) x 10

5

-TΔS

obs

-8.2 (± 0.4)

(kcal/mol)
12.8 (± 1.3)

-7.8 (± 0.3)

11.2 (± 0.8)

-7.9 (± 0.1)

4.9 (± 1.6)

Proton Release Graph

The observed enthalpies for the substrate binding reactions are plotted against the
enthalpy of ionization to yield buffer independent enthalpy of binding (y-intercept) and
the number of protons released (slope). The reactions included are: 4NC to FeHPCD
(green), HPCA to FeHPCD (red), and 4NC to MnHPCD (blue).
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Table 4.2

Hess’ Law for 4NC Binding to FeHPCD in HEPES buffer
Reaction

Coefficient

ΔH
(kcal/mol)

1

- 21.0

1.5
1

-4.9
-13.7

1.5 HEPES + 1 FeHPCD + 0.29 4NCH + 1.0 4NCH
2

1.5 HEPES-H+ + 1 FeHPCD-4NC
H+ + HEPES
HEPES-H+
4NCH + FeHPCD
FeHPCD-4NC + 1.5 H+
(2)

Table 4.3

Hess’ Law for 4NC Binding to FeHPCD in PIPES Buffer

Reaction
1.5 PIPES + 1 FeHPCD + 0.29 4NCH + 1.0 4NCH
2

1.5 PIPES-H+ + 1 FeHPCD-4NC
H+ + PIPES
PIPES-H+
4NCH + FeHPCD
FeHPCD-4NC + 1.5 H+
(2)

Table 4.4

Coefficient

ΔH (kcal/mol)

1

- 19.0

1.5
1

-2.7
-15.0

Hess’ Law for 4NC Binding to FeHPCD in Cacodylate Buffer

Reaction
1.5 cacodylate + 1 FeHPCD + 0.29 4NCH + 1.0 4NCH
2

1.5 cacodylate-H+ + 1 FeHPCD-4NC
+
H + cacodylate
cacodylate-H+
4NCH + FeHPCD
FeHPCD-4NC + 1.5 H+
(2)
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Coefficient

ΔH (kcal/mol)

1

- 12.8

1.5
1

0.71
-13.8

Table 4.5

The Buffer Independent Thermodynamic Terms for 4NC Binding to
FeHPCD

FeHPCD-4NC
HEPES
PIPES

(kcal/mol)
-13.7 (± 1.1)
-15.0 (± 0.8)

Cacodylate

Table 4.6

ΔHbinding

-13.8 (± 1.5)

HPCA
4NC

FeHPCD

1.2 (± 0.9) x 10
5.3 (± 2.8) x 10

6
5

5.90 (± 0.6) x 10

5

-TΔSbinding

-8.2 (± 0.4)

(kcal/mol)
5.6 (± 1.3)

-7.8 (± 0.3)

7.3 (± 0.8)

-7.9 (± 0.1)

6.0 (± 1.6)

Buffer Independent Thermodynamic Terms for Substrate Binding to HPCD
Proton Release

MnHPCD

ΔG
(kcal/mol)

K

HPCA
4NC

3.1 (± 0.26)
2.1 (± 0.40)

a

a,b

2.6 (± 0.02)
1.5 (± 0.25)

b
b

ΔHbinding

K
1.9 (± 0.6) x 10
2.6 (± 1.1) x 10
1.0 (± 0.6) x 10
7.7 (± 3.7) x 10

4
5
6
5

ΔG
(kcal/mol)

-TΔSbinding

(kcal/mol)
-4.2 (± 1.1)

(kcal/mol)
-1.6 (± 0.9)

-5.8 (± 0.2)

-24.3 (± 1.2)

-7.3 (± 0.3) 17.0 (± 1.3)

-16.9 (± 1.7)

-8.1 (± 0.4)

8.8 (± 0.6)

-14.2 (± 1.1)

-8.0 (± 0.2)

6.3 (± 0.9)

We have previously reported the thermodynamic binding parameters of HPCA to
FeHPCD, which are summarized in Table 4.6.41 Briefly, HPCA to FeHPCD binding
produced a favorable ΔHbinding of -16.9 (± 1.7) kcal/mol, and an unfavorable –TΔSbinding of
8.8 (± 0.6) kcal/mol, resulting in a Gibbs free energy of -8.1 (± 0.4) kcal/mol. The
equilibrium constant for the reaction was reported as 1.0 (± 0.7) x 106, consistent with
previously reported 1/Kd values by Groce et al.42 Proton release can be seen in Figure 4.4
(red line), which has a slope of 2.6 (± 0.02) protons.
Comparatively, the binding event of 4NC to MnHPCD was measured in three
buffers to yield a larger ΔHbinding of -24.3 (± 1.2) kcal/mol with 2.1 protons released
(Figure 4.4, blue line). The equilibrium constant for the binding reaction is 2.6 (± 1.1) x
105, which is comparable to the binding reaction of 4NC and FeHPCD. This yields a
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similar ΔG for the 4NC binding reaction at -7.3 (± 0.3) kcal/mol, leaving a large,
unfavorable -TΔS of 17.0 (± 1.3) kcal/mol. When the thermodynamic profiles of all
substrate binding reactions to the two metallated forms of HPCD are plotted and
compared, the similarities between 4NC and HPCA binding to FeHPCD become apparent
(Figure 4.5). The plotted data for 4NC binding to MnHPCD shows a Gibbs free energy
with the data for 4NC binding to FeHPCD, yet has substantially greater enthalpic and
entropic terms associated with binding. The observed thermodynamic values, Hess’ Law
interpretations, and corrected thermodynamic properties for 4NC binding to MnHPCD
can be found in Tables 4.7-4.11.
Table 4.7

Observed Thermodynamic Properties for 4NC-MnHPCD Binding

4NC-MnHPCD
HEPES
PIPES

ΔHobs

(kcal/mol)
-4.86

(kcal/mol)
-34.8 (± 1.9)

-2.68

MOPS

Table 4.8

ΔHionization

-5.04

ΔG
(kcal/mol)

K
3.3 (± 1.2) x 10

-30.1 (± 0.3)

1.5 (± 0.4) x 10

-35.2 (± 1.3)

3.0 (± 0.3) x 10

5
5
5

-TΔSobs

-7.5 (± 0.2)

(kcal/mol)
27.3 (± 2.1)

-7.1 (± 0.2)

23.1(± 0.2)

-7.5 (± 0.1)

27.7 (± 1.3)

Hess’ Law for 4NC Binding to MnHPCD in MOPS Buffer
Reaction

2.1 MOPS + 1 MnHPCD + 0.29 4NCH + 1.0 4NCH
2

2.1 MOPS-H+ + 1 MnHPCD-4NC
H+ + MOPS
MOPS-H+
4NCH + MnHPCD
MnHPCD-4NC + 2.1 H+
(2)
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Coefficient

ΔH
(kcal/mol)

1

- 35.2

2.1
1

- 5.0
- 24.7

Table 4.9

Hess’ Law for 4NC Binding to MnHPCD in HEPES Buffer
Reaction

2.1 HEPES + 1 MnHPCD + 0.29 4NCH + 1.0 4NCH
2

2.1 HEPES-H+ + 1 MnHPCD-4NC
H+ + HEPES
HEPES-H+
4NCH + MnHPCD
MnHPCD-4NC + 2.1 H+
(2)

Table 4.10

ΔH
(kcal/mol)

1

- 34.8

2.1
1

- 4.9
- 24.6

Hess’ Law for 4NC Binding to MnHPCD in PIPES Buffer
Reaction

2.1 PIPES + 1 MnHPCD + 0.29 4NCH + 1.0 4NCH
2

2.1 PIPES-H+ + 1 MnHPCD-4NC
H+ + PIPES
PIPES-H+
4NCH + MnHPCD
MnHPCD-4NC + 2.1 H+
(2)

Table 4.11

Coefficient

Coefficient

ΔH
(kcal/mol)

1

- 30.1

2.1
1

- 2.9
- 24.0

Buffer Independent Thermodynamic Terms for 4NC Binding to MnHPCD

Buffer
HEPES
PIPES
MOPS

ΔHbinding
(kcal/mol)
-24.6 (± 1.9)
-24.0 (± 0.3)
-24.7 (± 1.3)

ΔG
(kcal/mol)

K
3.3 (± 1.2) x 10
1.5 (± 0.4) x 10
3.0 (± 0.3) x 10
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5
5
5

-TΔSbinding

-7.5 (± 0.2)

(kcal/mol)
16.6 (± 2.1)

-7.1 (± 0.2)

17.1 (± 0.2)

-7.5 (± 0.1)

20.2 (± 1.3)

Figure 4.5

Thermodynamic Profiles for the Substrate Binding Reaction with HPCD

The Gibbs free energy (red), enthalpy of binding (blue), and entropy (-TΔS, green), are
profiled for each substrate binding reaction to the different metallated forms of HPCD.
A. HPCA binding to FeHPCD
B. 4NC binding to FeHPCD
C. HPCA binding to MnHPCD
D. 4NC binding to MnHPCD
In contrast, the thermodynamics associated with HPCA binding to MnHPCD has
an equilibrium constant that differs from the native form of HPCD by two orders of
magnitude (1.9 ± 0.6 x 104) (Figure 4.6). In order to observe the full binding isotherm for
this reaction, much higher concentrations of substrate and enzyme were used in 100 mM
MOPS buffer to yield a ΔHobs of approximately -19.8 (± 1.1) kcal/mol (Table 4.12).
However, because of the demand for such high concentrations of substrate and enzyme
for a single ITC experiment, ITC titrations were performed in MOPS buffer only, and a
well-established stopped-flow method to observe protons released from a reaction was
used in place of multiple buffer analysis by ITC.34-39
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Figure 4.6

Binding Isotherms for Substrate Binding to HPCD

The binding equilibrium is represented in the slope of the isotherm. These isotherms
represent the slightly changing K values for each substrate-enzyme system.
A. HPCA to FeHPCD in 25 mM PIPES buffer pH 7.2
B. 4NC to FeHPCD in 25 mM cacodylate buffer pH 7.2
C. 4NC to MnHPCD in 25 mM MOPS buffer pH 7.2
D. HPCA to MnHPCD in 25 mM MOPS buffer pH 7.2
Table 4.12

Observed Thermodynamic Properties for HPCA Binding to MnHPCD in
MOPS

ΔHionization

ΔHobs

(kcal/mol)
-5.04

(kcal/mol)
-19.8 (± 1.1)

K

ΔG (kcal/mol)

1.9 (± 0.6) x 10

4
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-5.8 (± 0.2)

-TΔSobs
(kcal/mol)
14.0 (± 0.9)

Because the rate of the substrate binding reaction and subsequent proton release is
slow in comparison to the ionization events of buffer and indicator, the rate of change in
absorbance of an indicator dye (ΔA/δt) can be related to the rate of proton release. We
have paired bromothymol blue with MOPS buffer because of their shared pKa value,
simplifying the relationship. By monitoring ΔA/δt using rapid mixing stopped-flow
techniques, we are able to observe the decay of the absorbance signal from the indicator
dye. By extrapolating back to time t = 0, we can calculate the number of protons released
during the binding event.
As a control experiment, the binding reaction of 4-NC to MnHPCD was analyzed
by the stopped-flow method, yielding 2.0 (± 0.4) protons released from the complex
(Figure 4.7). This is in excellent agreement with our ITC plot of ΔHobs vs ΔHionization in
three buffers, which yields a release of 2.100 (± 0.004) protons. When the binding
reaction of HPCA to MnHPCD was performed in the stopped-flow experiments in the
presence of an indicator dye, 3.1 (± 0.3) protons were released from the complex (Figure
4.8). Using this proton release number, the ΔHbinding was then calculated for the HPCAMnHPCD binding reaction to yield -4.7 (± 1.1) kcal/mol (Tables 4.13 and 4.14). The ΔG
and the –TΔSbinding terms for the binding event were calculated to be -5.8 (± 0.2) kcal/mol
and -1.1 (± 0.9) kcal/mol, respectively. In comparison to the thermodynamic profiles of
the three other complexes, it is apparent that while the HPCA-MnHPCD binding is
thermodynamically favorable, the enthalpic contribution is drastically reduced and the
binding reaction becomes slightly favorable in terms of entropy, which is distinctly
different from the other substrate-enzyme complexes.

125

Figure 4.7

Proton Release for 4NC-MnHPCD using the Stopped-Flow Method

The change in absorbance at time zero provides insight into the number of protons
released by the system. The indicator dye is sensitive to changes in ionization in the
environment, and proton release triggers a color change of the dye momentarily before
the protons are consumed by buffer in the bulk solvent. The inset shows the equation for
the slope of the line, and the y-intercept indicates the number of protons released, in great
agreement with the ITC data.
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Figure 4.8

Proton Release for HPCA-MnHPCD using a Stopped-Flow Method

The anaerobic binding of HPCA to MnHPCD was also performed using the stopped-flow
method. The inset shows the slope and y-intercept for the decay curve, where 2.9 protons
were released.
Table 4.13

Hess’ Law for the HPCA-MnHPCD Binding Reaction

Reaction
3.1 MOPS + 1 MnHPCD + 1.0 HPCA
3.1 MOPS-H+ + 1 MnHPCD-HPCA
H+ + MOPS
MOPS-H+
HPCA + MnHPCD
MnHPCD-HPCA + 3.1 H+

Table 4.14

1

- 19.8

3.1
1

- 5.0
- 4.2

Buffer Independent Thermodynamic Properties of HPCA Binding to
MnHPCD

HPCA-MnHPCD
MOPS

Coefficient ΔH (kcal/mol)

ΔHbinding
(kcal/mol)
-4.2 (± 1.1)

K
1.9 (± 0.6) x 10
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ΔG (kcal/mol)
4

-5.8 (± 0.2)

-TΔSbinding
(kcal/mol)
-1.6 (± 0.9)

4.4

Discussion
The most noticeable structural difference between 4NC and the native substrate,

HPCA, is the substituent bound to the catechol ring which has both electronic and
structural implications associated with substrate binding studies to HPCD. While both
catecholate substrates allow for turnover by FeHPCD, the differences between the
substituents on the ring could be playing distinctive roles in stabilizing the substrateenzyme complex, priming the active site center for O2 binding, and driving the reaction
forward. Our data indicates that the Gibbs free energies for the binding reactions of 4NCFeHPCD and HPCA-FeHPCD are nearly indistinguishable, leaving subtle differences
between these two binding events to lie within the enthalpy/entropy balance of the
process (Figure 4.5 A and B). Compared with our previously reported data on the HPCAFeHPCD binding event, the ΔHbinding for 4NC-FeHPCD is slightly smaller than that of
HPCA binding (Table 4.6), which is likely compensating for the smaller entropic penalty
in 4NC binding compared to the native substrate.41 This lowered enthalpy contribution
could be due to the electron withdrawing effects of the nitro group on the catechol ring,
providing less electron density to the iron(II)—O bond. In addition, small structural
changes, such as the subtle repositioning of amino acid residues during formation of the
enzyme-substrate complex could be the source of the difference in the change in entropy.
Such a subtle structural rearrangement could also lower the catalytic efficiency seen in
the turnover of 4NC by FeHPCD. For example, valine and arginine amino acid residues
(R293, R243, and V250) found within the loop region of the HPCD active site provide
favorable H-bonding interactions with the native substrate’s acetic acid moiety. However,
these interactions are slightly altered to accommodate the nitro moiety and provide
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stability for the 4NC-HPCD complex.12 Previous reports of 4NC binding also indicate a
multi-step process, where it is believed that the 4NC-FeHPCD complex undergoes
structural change during the binding event.42 Additionally, this entropy could be
attributed to the quantitative differences in total proton release between the two
substrates. However, the difference in enthalpy between these two substrates when they
bind to FeHPCD is a mere 3 kcal/mol, leading us to believe that these substrates have
very similar binding energetics and thus 4NC serves as an excellent substrate surrogate
for HPCA in the case of the native enzyme.
Perhaps more notable is the prominent difference in proton release from the two
substrate-enzyme complexes during the binding event. When the plots of the ΔHobs
against ΔHionization are compared for the two different substrates (Figure 4.4), it appears
that the HPCA-FeHPCD binding reaction releases one additional proton over the 4NC
binding process. Our data indicate that 4NC releases 1.5 (± 0.26) protons when it binds to
FeHPCD. This can be explained in terms of the protonation state of the catechol in
solution. The pKa values for the two hydroxyl protons on 4NC are 6.83 and 10.83,
leaving one hydroxyl fully protonated and the other retaining 0.29 protons at our working
pH of 7.2. Thus, when substrate binds, we net a loss of 1.29 protons, a value within the
error of our proton release graph. However, when HPCA binds to FeHPCD, we observe
2.6 (± 0.02) protons released. In this case, the pKa values of the hydroxyl protons are high
enough to be considered fully protonated at our experimental pH, while the carboxylic
acid on the tail is ionized at pH 7.2 (pKa = 11.25, 9.71, and 4.31). We speculate the 2.6
protons released from the HPCA binding reaction is tied to the loss of both hydroxyl
protons, in addition to 0.6 protons from the active site pocket as substrate binding
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perturbs the pKa values of local side chain residues that become more acidic in the
substrate-enzyme complex. The additional 0.6 proton released could be due to a change
in the hydrogen bonding network within the loop region which is proposed to support the
stabilization of the carboxylate substituent of HPCA.43 This interpretation suggests the
catechol-enzyme complexes formed, when either 4NC or HPCA bind to FeHPCD, have
the same ionization states (i.e. fully deprotonated) even though at neutral pH these
substrates have different ionization states in solution. To support this notion, more recent
computational analysis suggests that the Fe-O2 adduct is supported by a dianionic-bound
substrate, where previously it was believed that the superoxo species was supported by a
monoanionic substrate which was H-bonded to His200.9 Additional support for dianionic
binding comes from the high resolution structures available for the enzyme-substrate
complex of HPCA/FeHPCD (4GHG.pdb) and 4-NC/FeHPCD (4GHH.pdb).44 When
these structures are superimposed, the iron coordination geometry is highly similar
(Figure 4.9). Both substituted catechols bind to the iron(II) center in a slightly
asymmetric mode, and the local amino acids that have been implicated in H-bonding to
the enediol unit occupy virtually the same space. If these two substrates were bound in
different ionization states, the H-bonding network would likely be dramatically different
and significant changes would occur in the positioning of Asn157, Trp192, His200,
Arg243, His248, Tyr257, Val250, and Arg293. The major difference between these
structures seems to come from a very slight deviation of planarity of the iron(II)-catechol
unit. These structural similarities, collectively with our data suggests that in FeHPCD the
ionization state of the bound catechol is similar between HPCA and 4NC, in order to
effectively activate bound dioxygen.
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Figure 4.9

Overlay of 4NC and HPCA Bound to FeHPCD

The crystal structures of 4NC bound FeHPCD and HPCA bound FeHPCD were
superimposed to observe any differences in the positioning of local amino acid residues
that may give indication that the H-bonding network has changed between substrates.
These two structures are virtually indistinguishable, further supporting the notion that
these substrates bind to the metal in similar ionization states. The carbon atoms of
substrates HPCA and 4NC are colored white. Important residues in the active site pocket
are labeled. PDB Files: 4GHG and 4GHH. Image generated in PyMOL.
The substrate-enzyme binding reactions for MnHPCD concur with our FeHPCD
proton release data, where the number of protons released likely indicate a fully
deprotonated substrate. However, in the of MnHPCD complexes we see an additional
release of approximately 0.6 protons for each substrate-enzyme complex in comparison
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to FeHPCD (Table 4.4). For example, when HPCA binds to MnHPCD we observe a
release of 3.1 (± 0.26) protons from the system. We attribute this loss to 2.0 protons
directly from the deprotonation of the hydroxyl groups of HPCA, and an additional 0.6
proton from the active site pocket to support the hydrogen bonding network stabilization
of the catechol tail, as seen previously with HPCA-FeHPCD. Yet this leaves an
additional 0.6 protons unaccounted for in the MnHPCD system. To support these data,
the binding reaction of 4NC with MnHPCD loses 2.1 (± 0.4) protons, with 1.29 coming
directly from the substrate and leaving 0.8 protons unaccounted for, within error of our
additional 0.6 protons from the HPCA-MnHPCD reaction. This additional deprotonation
event could be the result of a greater pKa shift in the manganese(II) enzyme, suggesting a
more acidic local environment in MnHPCD. This idea is supported by studies of MndD, a
similar enzyme isolated from Arthrobacter globiformis.45,46 In this case, MndD contains
manganese(II) in its active site center, and also performs the catalytic conversion of
HPCA to 5CHMSA. Studies on the substrate-MndD complex and related model
complexes suggest a change in the H-bonding network supporting the manganese(II)
center of this enzyme.46 More specifically, this change occurs on the backside of the
active site pocket, where a H-bonding network from Arg152 through Asp154 to the δN-H
of His155 is thought to support a more basic histidine ligand to bind the manganese(II)
ion. This in turn would favor a more acidic manganese(II) ion and support a more stable
substrate-enzyme complex. This specific H-bond network is not observed in FeHPCD,
and is thought to be MndD specific. However, both crystal structures of the
manganese(II) form of HPCD indicate that Arg152 can occupy two different
conformations.30,47 One is identical to the iron(II) form which does not support a network
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of H-bonding from H155 through Asp154, while the other conformation clearly shows Hbonding possibilities for the abovementioned amino acid residues in addition to new
amino acid contacts (Figure 4.10).30,48,49 Whether or not this change in the interactions of
local residues on the backside of the active site pocket directly influences the acidic
nature of the manganese(II) center has not been determined, however the clear change in
conformation of Arg152 and resulting interactions is highly likely to be responsible of
our additional proton release of 0.6 protons in the substrate-MnHPCD complexes.
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Figure 4.10

Comparison of the Hydrogen Bonding Network in MndD and MnHPCD

The residues on the backside of the active site pocket could support the 2H1C facial triad
through H-bonding.
A. MndD residue interactions that are thought to make His155 more basic, supporting a
more acidic manganese(II) ion. PDB File: 1F1V. Image generated in PyMOL.
B. The same residues in MnHPCD. Arg152 clearly occupies two different conformations
(red solid circle) as seen in both crystal structures of the enzyme. The first conformation
(red dotted circle) is identical to FeHPCD, where distances between Arg152 and all
residues are too great to support any interactions. The other conformation shows
interactions with Asp154 through H-bonding with a water molecule, and additional
interactions with waters and amino acid residues on the opposite side. These interactions
could be the cause of the additional 0.6 proton loss seen in the MnHPCD enzyme. PDB
File: 3OJN. Image generated in PyMOL.
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Manganese(II) substituted HPCD has proven to be just as catalytically efficient as
FeHPCD, providing almost identical binding affinities and rates of turnover for the native
substrate as the iron(II) enzyme.30 From this, it is thought that MnHPCD operates through
the same mechanism as FeHPCD to convert HPCA to 5CHMSA. Conversely, the
thermodynamic profile of HPCA-MnHPCD is distinctly different than the profile for
HPCA-FeHPCD binding reaction (Figure 4.5). Not only does the binding of HPCA to
MnHPCD have a smaller enthalpic contribution and a binding equilibrium two orders of
magnitude smaller than HPCA-FeHPCD, the –TΔS term for HPCA-MnHPCD is slightly
favorable. This could be attributed to the release of water from the active site center. In
computational studies of FeHPCD, optimization of the substrate-enzyme complex
involves an open sixth coordination site.50 However, theoretical studies performed on
MndD have the sixth coordination site still occupied by a water molecule.31 It is possible
that the electron donating effects of HPCA could be supplying enough electron density to
the manganese(II) center to destabilize the bound water, making it more labile. If this is
true, bond breakage could consume up to 28 kcal/mol of heat,51 making our enthalpic
values for this process low. Adjustment to the buffer independent value to account for the
heat consumed by water release results in an enthalpy of binding of -32.2 kcal/mol and a
–TΔS term of 26.4 kcal/mol, much more in line with the data obtained for 4NCMnHPCD. Conversely, the electron withdrawing effects of the 4NC substituent may
result in 4NC not supplying enough electron density to the manganese(II) ion, thus the
water is less labile and remains in the sixth coordination site. This non-labile water
molecule could explain why MnHPCD does not catalyze ring-cleavage of the 4NC
substrate.30,52 On the contrary, iron(II) in FeHPCD is acidic enough to result in a labile
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water molecule when 4NC is bound, and turnover results. However, our deconvolution of
the binding enthalpy in this case is limited because there is no known enthalpic value of
water association/dissociation to an iron(II) ion. Even if the value was similar to the
published manganese(II) data, the enthalpy for substrate binding between iron(II) and
manganese(II) forms of HPCD would be quite different in magnitude.
A curious question is why the thermodynamic profiles look so distinctly
different for the manganese(II) form of HPCD in comparison to the iron(II) form. An
answer to this question could lie within the electronic contributions from both the metal
and substrate that help stabilize the substrate-enzyme complex. A detailed theoretical
study performed on MndD indicated that although it follows the same mechanism as
FeHPCD,31 the energetics for the reaction were quite different.53 Here, it was indicated
that the manganese(II) center undergoes a spin transition to accomplish the same
chemistry that the iron(II) center catalyzes. Perhaps this is the case for the manganese(II)
form of HPCD as well. Although the computational studies demonstrate that the spin
transition occurs during O—O bond cleavage, our stark differences in the thermodynamic
profiles of substrate binding suggest that the changes in the free energies in the reaction
coordinate (and the enthalpy/entropy terms associated with them) proposed by P.
Siegbahn and coworkers could start much earlier than the O—O bond cleavage step.53
4.5

Conclusion
In summary, we observe unique energy profiles associated with substrate binding

to each metal ion for the superimposable forms of HPCD. This suggests the O2 activation
chemistry might differ between the manganese(II) and iron(II) forms of the protein, and
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may be due to the electronic contributions from the metal(II) ion causing slight
differences in the energetics of the catalytic mechanism it follows.
Broadly speaking, we have provided the complete thermodynamic properties for
the binding of the two most influential substrates to native and manganese(II) substituted
HPCD. We observe thermodynamically favorable Gibbs free energies for all binding
reactions, and our data supports the notion that the enediol unit of the catechols are
dianionic when coordinated to either iron(II) or manganese(II) in HPCD, which has a
dramatic impact on our understanding of the catalytic mechanism of extradiol
dioxygenases. Theoretical studies suggest this dianionic state may not be the most stable
substrate-enzyme complex, however this instability and the related protein-based
interactions could be crucial in driving the reaction forward.
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CHAPTER V
ENERGETICS OF IRON(II) BINDING TO THE 2-HIS-1-CARBOXYLATE FACIAL
TRIAD IN AN α-KETOGLUTARATE-DEPENDENT ENZYME

5.1

Introduction
As we have seen, mononuclear nonheme iron(II) sits at the active site center of

many biologically relevant enzymes.1-4 Many of these enzymes contain an iron(II) ion
that is able to transform into a high valent intermediate species, which is essential for the
biological processes they catalyze. To afford such chemistry, a common metal ligation
motif is shared among a vast population of the nonheme iron(II) enzymes that involves
the side chains of two histidine residues and one carboxylate-containing side chain from
an aspartate or glutamate residue to make up what is commonly referred to as the 2-His1-carboxylate (2H1C) facial triad.5,6 This ligand configuration allows the endogenous
ligands to occupy one face of the iron(II) octahedral coordination sphere, leaving the
opposite face coordinated to solvent ligands which can be easily replaced by substrates
(see Figure 1.2 A). The dioxygenase family of enzymes contain the 2H1C facial triad
which offers proximity of the substrate(s) and dioxygen to warrant efficient catalysis of
reactions such as the repair of alkylated DNA/RNA by AlkB and ABH enzymes, the
biosynthesis of penicillin by isopenicillin N synthase (IPNS) and deacetoxycephalosporin
C synthase (DAOCS), and hypoxic response by hypoxia-inducible factor (HIF).6-9
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Scheme 5.1 The TauD Catalyzed Reaction
The TauD catalyzed reaction is a coupled reaction where αKG is decarboxylated to
succinate and carbon dioxide to yield a high valent iron(IV)-oxo species that oxidizes
taurine to aminoacetaldehyde and sulfite.
A subfamily of oxygenase enzymes whose metal binding mode is comprised of
the 2H1C motif are the α-ketoglutarate (αKG)-dependent enzymes.10 The most wellstudied member and often thought of as the model system of the αKG dependent
subfamily of enzymes is αKG/taurine dioxygenase (TauD), an enzyme that catalyzes the
coupled reaction of oxidative decarboxylation of αKG and oxidation of taurine to liberate
sulfite (Scheme 5.1).11 TauD contains residues His99, Asp101, and His255 that act as the
2H1C ligands (Figure 5.1), allowing bidentate binding of αKG on the opposite face.
Here, the keto oxygen binds trans to the Asp ligand, and the C1 carboxylate oxygen
binds trans to His99.12,13 It has been found that this particular binding orientation of αKG
is crucial for the reaction to take place, which leaves the sixth coordination site trans to
His255 for dioxygen binding and activation to occur.14,15 Previous studies have
demonstrated that several divalent metal ions can also bind to the 2H1C facial triad of
TauD; however, iron(II) is the only metal(II) ion that is capable of providing catalytic
activity.16,17 Using sophisticated global regression analysis of UV absorbance spectra, the
Kd of iron(II) binding to the TauD apoprotein was determined to be approximately 90 (±
40) nM. In this study, we explore the energetics of iron(II) binding to TauD and
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determine the underlying driving forces behind the coordination of iron(II) to the 2H1C
facial triad.

Figure 5.1

The TauD Active Site

The 2H1C ligands (green) bind the iron(II) ion on one face of the octahedral coordinating
sphere, leaving the adjacent face for bidentate binding of αKG (white) trans to ligands
His99, and Asp101. The sixth coordination site is open for dioxygen binding trans to
His255. The primary substrate taurine (blue) binds near to the metal center for facile
oxidation. PDB File: 1OS7. Image generated in PyMOL.
5.2
5.2.1

Materials and methods
Reagents and general procedures
All buffers and reagents were of the highest grade available and used as received.

All solutions used in experimentation were prepared in 18 MΩ water that was purified
using a Millipore Ultrapurification system. The glass dialysis containers and vials for
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apoprotein storage were first rinsed with ethylenediaminetetraacetic acid (EDTA) before
rinsing thoroughly using 18 MΩ water before use.
5.2.2

Overexpression and purification of α-ketoglutarate/taurine dioxygenase
TauD was overexpressed using E. coli BL21(DE3) cells containing the plasmid

pME4141.16 The collection and purification of TauD was performed by previously
established methods, and spectroscopic assays were carried out to determine the enzyme
activity.18 TauD was generated by the research group of Robert P. Hausinger (Michigan
State University) for collaborative purposes.
5.2.3

Isothermal titration calorimetry
The procedures for the metal binding experiment using ITC can be found in the

recently published literature.18 The purified TauD apoprotein stock was diluted to 100
μM and dialyzed 2 times against 1 L of 25 mM buffer at pH 7.4 for 3 hours each, and
dialyzed a third time against 1 L of 25 mM buffer at pH 7.4 overnight. TauD and the
dialysate were made anaerobic by purging with Ar. A 3.3 mM iron(II) acetate solution
was prepared in an anaerobic environment using the degassed dialysate. A MicroCal VPITC instrument was sealed in an anaerobic chamber (Plaslabs) with constant N2 flow
during the course of the experiment. All data were collected at 25 0C unless noted
otherwise for heat capacity studies. Injections of 3 uL iron(II) acetate solution were
introduced to the cell containing TauD over a 6 s period with 300 s spacing between
injections. Chelation titration experiments were also performed on TauD. The TauD
apoprotein stock was diluted to 50 μM in 25 mM HEPES buffer pH 7.4 and exhaustively
dialyzed per procedures mentioned above. An 800 μM EDTA solution was prepared with
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the dialysate and all samples were degassed by purging with Ar. An iron(II) acetate
solution was added using anaerobic techniques to TauD to achieve a mole ratio of 0.95.
ITC data were collected at 25 0C using 6 μL injections of EDTA into metal-bound TauD
(Fe2+TauD) over a 12 s period with 300 s spacings between injections. For all experiment
sets, control experiments were performed and raw heats generated by the control
experiments were subtracted as necessary from the experimental data. Data were
analyzed using the Origin (OriginLabs) software package designed for MicroCal data
analysis, and using CHASM software developed in the laboratory of Edwin Lewis
(Mississippi State University), which uses a nonlinear least-squares model to fit the
change in heat per injection to equilibrium binding model equations.19 The isotherms for
iron(II) binding to TauD in various buffers, as well as the chelation titration experiment
were all performed 2-4 times to obtain replicate data.
5.3

Results
The binding reactions of both metal ions and substrates to macromolecular

systems often generate a heat of binding which can be monitored through the use of ITC.
20,21

In a single experiment, we can directly monitor the heat, or observed enthalpy

(ΔHobs) for the reaction, the binding stoichiometry, and the binding equilibrium constant
(K), allowing for the calculation of Gibbs free energy (ΔG) and the entropy (ΔS) terms
using the thermodynamic equations 2.1 and 2.2. All entropy terms stated in herein are
reported in terms of –TΔS as a means to provide a more straightforward comparison of all
the thermodynamic terms.
The observed enthalpy terms that are obtained from the direct titration of iron(II)
into TauD are more appropriately described as a complex series of competitive binding
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events due to metal ion complexation with the buffer. In addition, metal binding to a
macromolecule often results in release or uptake of protons by the system, which results
in the production of additional heat from the ionization of the buffer (ΔHionization). The
well-known ΔHionization terms can then be exploited through a plot of the ΔHionization against
the ΔHobs to yield a linear relationship where the slope is equal to the number of protons
(np) released or consumed by the system during the metal binding event. This relationship
is expressed in the following equation:
ΔHobs + ΔHFe-buffer = (ΔHFeTauD - npΔHH-TauD) + np(ΔHionization)

Eqn 5.1

In order to obtain the ΔHFe-buffer term, ITC control experiments were performed by
titration of the metal-buffer complex into EDTA. ΔHobs for these sets of reactions were
used in a Hess’ Law relationship to extract the ΔHFe-buffer term. The buffers for the metal
binding experiments were 2-(carbamoylmethylamino)ethanesulfonic acid (ACES), 2-(Nmorpholino)ethanesulfonic

acid

(MOPS),

and

2-[4-(2-hydroxyethyl)piperazin-1-

yl]ethanesulfonic acid (HEPES) buffers, chosen for their pH range and minimal heats of
interaction with the metal ion and TauD. The raw heats and integrated isotherms for the
control experiments are shown in Figures 5.2-5.4, followed by the Hess’ Law reaction
tables (Tables 5.1-5.3).
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Figure 5.2

ITC Control Experiment of Fe2+-ACES into EDTA in ACES Buffer, pH
7.418

This experiment was performed to elucidate the enthalpy of the Fe2+-ACES interaction,
which was then used to deconvolute the Fe2+TauD experiments.

147

Table 5.1
2+

Hess’ Law for Fe2+-ACES Enthalpy Determination
+

Fe ACES + H EDTA

Reaction
Fe2+EDTA + ACES-H+

Coefficient

ΔH (kcal/mol)
-3.48

HEDTA3- + H+

.05

4.2a

EDTA4- + H+

1.0

5.4a

ACES-H+

1.05

-7.27b

[FeEDTA]2-

1

-4.0a

1

2.5

H2EDTA2HEDTA3ACES + H+
Fe2+ + EDTA4Fe2+ACES

Fe2+ + ACES
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Figure 5.3

ITC Control Experiment for Fe2+-HEPES into EDTA in HEPES Buffer, pH
7.418
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Table 5.2

Hess’ Law for Fe2+-HEPES Enthalpy Determination

Reaction
Fe2+HEPES + H+EDTA
Fe2+EDTA + HEPES-H+
H2EDTA2HEDTA3HEPES + H+
Fe2+ + EDTA4Fe2+HEPES

Coefficient ΔH (kcal/mol)
-1.58

HEDTA3- + H+

.05

4.2a

EDTA4- + H+

1.0

5.4a

HEPES-H+

1.05

-4.86b

[FeEDTA]2-

1

-4.0a

Fe2+ + HEPES

1

1.9

Value a denotes this value was taken from the literature reference 22, and value b was
taken from reference 23.
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Figure 5.4

ITC Control Experiment of Fe2+-MOPS into EDTA in MOPS Buffer, pH
7.418

151

Table 5.3

Hess’ Law for Fe2+-MOPS Enthalpy Determination

Reaction
Fe2+MOPS + H+EDTA
Fe2+EDTA + MOPS-H+
H2EDTA2HEDTA3MOPS + H+
Fe2+ + EDTA4Fe2+MOPS

Coefficient

ΔH (kcal/mol)
-1.85

HEDTA3- + H+

.05

4.2a

EDTA4- + H+

1.0

5.4a

MOPS-H+

1.05

-5.04b

1

-4.0a

1

1.83

[FeEDTA]2Fe2+ + MOPS

Value a denotes this value was taken from the literature reference 22, and value b was
taken from reference 23.

For the direct titration of the iron(II) acetate solution into TauD apoprotein, all
raw data were control-subtracted and baseline corrected. Integration of the raw heats
afforded binding isotherms that were fit for a single site binding and yielded ΔHobs values
for the reaction in HEPES, MOPS and ACES buffers. A plot of the ΔHionization against the
ΔHobs + ΔHFe-buffer values indicates 0.9 protons are released during iron(II) binding to the
2H1C of TauD (Figure 5.5).18 A list of the observed thermodynamic properties for the
titration of iron(II) into TauD in each buffer is found in Table 5.4. The error bars
associated with the collection of data in ACES buffer are larger in magnitude than those
observed for the reaction in other buffers due to the averaging of titrations with different
batches of purified TauD. The goodness of fit in the slop (R2 = 1.00) leads us to believe
that the data represented here is accurate and satisfactorily represents the average binding
enthalpy of iron(II) to TauD apoprotein.
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Figure 5.5

Enthalpy Plot of the Direct Titration of Iron(II) into TauD Apoprotein18

The plot of the observed enthalpy for iron(II) binding to TauD apoprotein plotted against
the ionization of the buffers used in the study. The slope of the line indicates that 0.9
protons are released by the system when iron(II) binds to the 2H1C facial triad of TauD.
Table 5.4

Observed Thermodynamic Properties of Iron(II) Binding to TauD18
n

MOPS
HEPES
ACES

0.78
(± 0.13)
0.85
(± 0.13)
0.94
(± 0.07)

Kobs
5.4 (± 0.7) x 10
3.3 (± 0.6) x 10
1.0 (± 0.7) x 10

5

5

7

ΔHobs

ΔHionization

ΔGobs

-TΔSobs

(kcal/mol)
-2.2
(± 0.3)
-1.9
(± 0.5)
-3.9
(± 0.8)

(kcal/mol)

(kcal/mol)
-7.8
(± 0.1)
-7.5
(± 0.1)
-9.2
(± 1.0)

(kcal/mol)
-5.7
(± 0.4)
-5.6
(± 0.4)
-5.3
(± 1.5)

-5.04
-4.86
-7.27

By using the observed enthalpy values obtained for iron(II) binding to TauD in
three buffering systems, Hess’ Law can be applied to account for all the known equilibria
taken place in solution during the binding reaction (Tables 5.5-5.7). There are many
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tables similar to these that have been generated for the calculation of binding enthalpies
in a number of metal binding to small peptides and protein systems.24-26 The overall
reaction includes the dissociation of the iron(II) ion from the metal-buffer complex,
iron(II) binding to the active site center in TauD, an ionization event that takes place
when iron(II) binds which is presumably from a pKa shift of water molecules bound to
the iron(II) center, and protonation of the buffer in bulk solvent to help maintain the pH
at 7.4. When all of these variables are taken into account, the average enthalpy of iron(II)
binding to TauD (ΔHFeTauD) is estimated to be -11.7 (± 0.3) kcal/mol. A complete list of
the change in enthalpy values for iron(II) binding to TauD determined by using Hess’
Law calculations can be found in Table 5.8.
Table 5.5

Hess’ Law For Iron(II) Binding to TauD in ACES Buffer pH 7.418

Reaction
Fe2+-ACES + TauD-H+0.9

Fe2+-TauD +

Coefficient

-3.9a

ACES-H+0.9 + 0.1 ACES
Fe2+-ACES
TauD-H+

ΔH (kcal/mol)

Fe2+ + ACES

1.0

2.5b

TauD + H+

0.91

13.34c

ACES + H+

ACES-H+

0.91

-7.27d

Fe2+ + TauD

Fe2+-TauD

1.0

-11.94

a

Measured value taken from ITC experiments. bCalculated value from control
experiments. cValue taken from the literature.22 dValue taken from the literature.23
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Table 5.6

Hess’ Law for Iron(II) Binding to TauD in HEPES Buffer pH 7.4 18

Reaction
Fe2+-HEPES + TauD-H+0.9

Coefficient

ΔH (kcal/mol)
-1.9a

Fe2+ + HEPES

1.0

1.9b

TauD + H+

0.91

13.34c

Fe2+-TauD +

HEPES-H+0.9 + 0.1 HEPES
Fe2+-HEPES
TauD-H+
HEPES + H+

HEPES-H+

0.91

-4.86d

Fe2+ + TauD

Fe2+-TauD

1.0

-11.53

a

Measured value taken from ITC experiments. bCalculated value from control
experiments. cValue taken from the literature.22 dValue taken from the literature.23

Table 5.7

Hess’ Law for Iron(II) Binding to TauD in MOPS Buffer pH 7.4 18

Reaction
Fe2+-MOPS + TauD-H+0.9

Coefficient

ΔH (kcal/mol)
-2.17a

Fe2+ + MOPS

1.0

1.83b

TauD + H+

0.91

13.34c

Fe2+-TauD +

MOPS-H+0.9 + 0.1 MOPS
Fe2+-MOPS
TauD-H+
MOPS + H+

MOPS-H+

0.91

-5.04d

Fe2+ + TauD

Fe2+-TauD

1.0

-11.55

a

Measured value taken from ITC experiments. bCalculated value from control
experiments. cValue taken from the literature.22 dValue taken from the literature.23
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Table 5.8

Average ΔHFeTauD for Iron(II) Binding to TauD18
25 mM Buffer
pH 7.4
MOPS

ΔHFeTauD
(kcal/mol)
-11.46 (± 0.01)

HEPES

-11.53 (± 0.49)

ACES

-11.94 (± 0.83)

Average

-11.64 (± 0.25)

The values listed for each buffer are the average of three data sets. The average ΔHFeTauD
is the average of all nine data sets and the errors listed are one standard deviation from
the mean.

The complex equilibria in solution not only have an effect on the ΔHobs, observed
K value for the direct titration of iron(II) into TauD is convoluted as well. This Kobs value
is the product of the iron(II) into TauD association constant and the dissociation constant
of the metal-buffer complex. To our knowledge, the binding equilibria for iron(II)-buffer
complexes are not known and therefore the K obtained from the direct titration of iron(II)
into TauD cannot be deconvoluted. In order to obtain a more accurate Ka term for the
binding reaction, a second set of experiments were performed that involve chelation of
the iron(II) center from TauD using EDTA. The metal-EDTA binding equilibrium is
known, which allows for the calculation of the Ka for iron(II) binding to TauD using the
mathematical description below:
Ka = KEDTA / Kobs (where Ka = 1/Kd FeTauD)

Eqn 5.2

The integrated isotherm for the observed chelation titration includes single site binding
and significant endothermic features that occur after one equivalent of EDTA (blue dots,
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Figure 5.6). These dilutions could be associated with chelation of metal from a second
binding process, which is commonly seen in both the direct titration and chelation
experiments for TauD and other enzyme systems.26 For the chelation titration, this
additional process could be attributed to weak binding of an adventitious site as
previously reported for the TauD enzyme,12 or structural rearrangement of the newly
formed metal-EDTA complex. A non-protein iron(II) control experiment was performed
and the data (Figure 5.7 red dots), which reflect the same endothermic pattern as seen in
the control experiment in Figure 5.4, were subtracted to yield a more symmetric one-site
binding event (Figure 5.6 grey dots). The isotherm was then fitted to a one-site binding
model to obtain a Kobs for the chelation experiment of 8.4 (± 0.4) x 106.18 It should be
noted that the data can be fit for two-site binding without the removal of the additional
process to yield similar Kobs values, however we believe our method of subtraction
provides the most accurate values for the data.
By using equation 5.2, we calculate the Ka for Fe2+-TauD to be 2.4 (± 0.1) x 107,18
which is in excellent agreement with the previously published value.17 Using this value
and equations 1 and 2, we obtain a Gibbs free energy for the binding equilibrium of -10.1
(± 0.03) kcal/mol and a –TΔS term of 1.6 (± 0.3) kcal/mol which indicates a highly
enthalpy-driven iron(II) binding event. The complete thermodynamic profile for iron(II)
binding to the 2H1C of TauD is shown in Figure 5.7.18
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Figure 5.6

Integrated Isotherm for the EDTA Chelation of Iron(II) from TauD18

The observed isotherm (blue) was adjusted by subtracting a non-protein iron(II) control
(red) to yield a more symmetric one site binding model (grey).
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Figure 5.7

Thermodynamic Profile for Iron(II) Binding to TauD18

This profile illustrates that the metal binding event is highly enthalpy driven, leaving a
slightly unfavorable –TΔS term.
To further probe the nature of the unfavorable entropy term during the metal
binding event, a heat capacity study was performed at three different temperatures in 25
mM MOPS buffer pH 7.4. The raw heats and integrated isotherms for iron(II) binding to
TauD at 5 0C and 15 0C can be seen in Figure 5.8. By performing the iron(II) binding
titration at 5 0C, 15 0C, and 25 0C, the ΔHobs for the reaction can be plotted against the
temperature to give a slope of the linear correlation that is equal to the ΔCp for the
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reaction (Figure 5.9).18 In the case of iron(II) binding to TauD, the ΔCp was determined to
be 0.0389 (± 0.0138) kcal/mol ∙ K, a very small positive value as expected from the
unfavorable entropy term. By using the statistical thermodynamics equation that relates
heat capacity to solvent molecules:
ΔCp = N3R

Eqn 5.3

Where N is the number of solvent molecules gained or released and R is the gas constant,
iron(II) binding to TauD has a gain of approximately 6.5 (± 2.3) water molecules.

Figure 5.8

Representative Raw Heat and Integrated Isotherms for TauD

A. The raw heat and integrated isotherm for iron(II) binding to TauD at 5 0C.
B. The raw heat and integrated isotherm for iron(II) binding to TauD at 15 0C.
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Figure 5.9

Heat Capacity Graph18

The slope of the linear relationship between the observed enthalpy and the temperature at
which the reaction was performed yields the heat capacity for the binding reaction. In this
case, the ΔCp is approximately 39 cal/mol∙K.

5.4

Discussion
As previously discussed, the 2H1C facial triad motif is often used in non-heme

iron(II) oxygenase enzymes to help stabilize a metal center capable of catalyzing
oxidation reactions.27,28 It does this by using the side chains of two histidine residues, and
either a glutamate or an aspartate residue that is able to supply a negative charge in the
binding motif, dramatically stabilizing the iron(II) ion and lowering the overall charge on
the iron(II) complex. In this study, we measured iron(II) binding to the 2H1C facial triad
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by using TauD, the a highly studied αKG-dependent enzyme and model system for this
family of non-heme iron(II) oxygenases.
The iron(II) binding event in TauD is highly favorable, where one metal ion binds
per monomer with a ΔG of -10.1 (± 0.03) kcal/mol. Table 5.4 indicates that the number of
metal ions (n) bound to TauD is substoichiometric. We attribute this to residual divalent
metal ions in the TauD apoprotein solution. This was confirmed through a control
experiment in which EDTA was titrated into apoprotein, and approximately 0.2 molar
equivalents of a divalent metal ion were observed to bind (Figure 5.10).
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Figure 5.10

Control Titration of EDTA into TauD Apoprotein

The first two peaks in the raw heat of the ITC data (top figure) indicate that divalent
metal ions are chelated by the EDTA when it is injected. This is equivalent to
approximately 0.2 molar ratio and justifies the substoichiometric ratio of iron(II) binding
to TauD.
The favorable Gibbs free energy for the iron(II) binding event is highly driven by
the enthalpic contributions for the coordination process. The ΔHobs term includes the
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coordination of iron(II) to the three endogenous ligands, coordination of water molecules
to the available face of the iron(II) octahedral coordinating sphere, as well as a proton
release event. We hypothesize this proton release is associated with the ionization of
water when it coordinates to the iron(II) ion. Oftentimes, the Lewis acidity of a metal ion
can result in a reduction in the pKa of coordinated water molecules.24,26,29 In the case of
iron(II) binding to TauD, coordination of water molecules to the iron(II) would result in
the average reduction in the pKa to approximately 7.8, as calculated by using the
Henderson-Hasselbalch equation. However, each coordinated water molecule most likely
exists in its own microstate dependent on the location of the molecule in the coordination
sphere. Regardless, the net release of 0.9 protons as a result of this shift provides an
additional 12.0 kcal/mol in enthalpic instability during iron(II) binding. If this additional
ionization event is accounted for in Hess’ Law, the enthalpy of iron(II) binding becomes
a highly favorable process (-11.6 ± 0.3 kcal/mol). Alternatively, the proton density could
be released from a local residue within the active site pocket, namely His255 and His99,
when they ligate to the iron(II) ion. From this perspective, approximately 96 % of free
histidines are in neutral form in a solution at pH 7.4. If the histidines within the active site
pocket are in the neutral state, then the Lewis acidity of the bound iron(II) ion could
lower the pKa of the proton residing on the δ nitrogen, resulting in additional proton loss.
The ionization event for a free histidine residue is reported to be 10.5 kcal/mol,22,29 and
by substituting this value in for the ionization event of TauD in table 5.7, the enthalpy of
iron(II) binding can be calculated to be 9.0 kcal/mol, which also has a destabilizing effect
on the enthalpy of binding and is within 3 kcal/mol of our ΔHbinding value listed in Table
5.8. However, the ionization enthalpy values of a histidine residue bound to iron(II) are
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not known, and the actual pKa of the histidine residues within the hydrophobic active site
pocket are not published to our knowledge, hindering the thermodynamic analysis for this
possibility.
Iron(II) binding studies are scarce in the literature. A more recent report measured
iron(II) binding to a histidine rich sequence of a peptide related to the iron-regulated
transporter IRT1, where the ΔHbinding is -6.5 kcal/mol.24 It is unclear whether or not this
calculation included the ionization of water molecules coordinated to the iron(II)
octahedral sphere, however calculations are provided for other metals binding to the same
ligand motif where the ionization of histidine residues is presented. Overall, iron(II)
binding to the three histidine motif in IRT1 is much less favorable; the ΔG for the binding
reaction is -3.9 kcal/mol indicating a much weaker K than we have obtained for the 2H1C
motif.20,24 To further support this notion, low binding equilibria have been inferred for the
three

histidine-containing

acetylacetone

2,3-dioxygenase

(Dke1)

as

well.1,30,31

Comparatively speaking, it appears that the 2H1C facial triad binding motif is the
energetically preferred binding motif for iron(II) in biological systems.
In another iron(II) binding study, iron(II) binding to an α-helical-rich keratin
complex suggest that the favored coordination mode of iron(II) is with two glutamate
residues with the α-helix which supplies a ΔHobs of -0.86 kcal/mol.32 Obviously, this
would indicate a highly entropically driven binding event, which is expected from a
system that involves charge-charge stabilization and water release when the divalent
metal binds.33 However, the metal-binding event is favorable in terms of Gibbs free
energy as indicated by a large binding equilibrium (2.8 x 105).32 Our results indicate a
large binding equilibrium and a largely favorable change in enthalpy for iron(II) binding
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to TauD. This result is consistent with the charge stabilization stemming from the
negatively charged aspartate residue in addition to favorable contacts with the imidazole
ring of the histidine side chain residues to provide the most favorable thermodynamic
terms for the 2H1C metal binding motif. However, solvation and conformational changes
should not be overlooked, as they can also play a major role in the free energy of iron(II)
coordination, which limits our detailed comparison of TauD with IRT1 and the keratin
systems.
Our –TΔS term indicates that iron(II) binding to TauD is slightly unfavorable at
1.6 (± 0.4) kcal/mol.18 This energy compensation for the enthalpically driven binding
event in many macromolecular systems usually comes from structural reorganization
upon uptake of the metal ion or substrate. Previous studies on TauD conformational
change during metal binding indicate that there is no substantial structural reorganization
when the enzyme ligates iron(II) in the active site center.17 Alternative processes that may
contribute to the –TΔS include: an overall gentle relaxation or rigidity of the TauD
structure providing more flexibility (or conversely, structure) to the enzyme; water
reorganization within or at the surface of the enzyme; an altered H-bonding network
between amino acid residues once iron(II) is bound; proton release, as indicated by our
ITC experiments; and buffer release to bulk solvent from the iron(II)-buffer complex
(approximately 1-2 buffer molecules per divalent metal ion, dependent upon the buffer
used in the study). The composition of all these terms during the dynamic iron(II) binding
reaction, in addition to charge stabilization at the iron(II) center, may result in a
negligible net change during metal coordination; this would explain why the entropy term
is almost zero. To gain insight into the role of water molecules in the iron(II)
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coordination process, we have also completed the titration experiments at various
temperatures to give rise to the change in heat capacity during iron(II) binding to TauD.
This study resulted in a small, positive change in the heat capacity (approximately 39
cal/mol∙K) over a 20 K range in temperature. As the temperature increases, we observe a
decrease in ΔHobs while a slight increase in –TΔS occurs. Higher temperatures can cause
more favorable entropy terms, where the increase in heat corresponds with an increase in
the vibrational and rotational energies, and can contribute to a more favorable –TΔS. This
process can create a balance between the entropy and enthalpy terms, resulting in no
observable change in the Gibbs free energy for the system over a 20 K temperature range.
However, if we further analyze the heat capacity in terms of water molecules, we
can apply the statistical thermodynamic equation 5 above to determine that a net gain in
water molecules to the Fe2+-TauD complex results. Specifically, we observe
approximately 6.5 water molecules becoming ordered within and at the surface of the
Fe2+-TauD complex upon iron(II) coordination to the 2H1C facial triad ligands. This
could stem from the three water molecules coordinated to the iron(II) octahedral
coordinating sphere, and additional water molecules that help stabilize the organized
structure once iron(II) is bound to the 2H1C. This notion also helps to explain the source
of unfavorable entropy observed in the iron(II) equilibrium with TauD.
5.5

Conclusion
This study has established the energetics of iron(II) binding to TauD by a

collection of experiments involving the direction titration of iron(II) into apoprotein, and
EDTA chelation titration experiments with the Fe2+-TauD complex. The iron(II) binding
reaction is highly favorable in Gibbs free energy (-10.1 kcal/mol) and is clearly an
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enthalpy driven process which is led by an ionization event that we attribute to the loss of
0.9 protons from water molecules coordinated to the iron(II) center. Upon iron(II)
binding, it appears that water is reorganized either at the surface or within the active site
pocket of Fe2+-TauD, which suggest a change in the H-bonding network within the
enzyme. This provides clarity to the driving forces behind iron(II) binding to TauD, and
appears to be the more energetically stable binding motif for non-heme iron(II) in
biological systems. However, it remains to be seen if this is a generalized trend across the
2-His-1-Carboxylate facial triad enzymes, and if the favorable free energy for the iron(II)
binding event provides additional global stability to the enzyme complex.
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